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The aim of this study was to investigate the characteristics of an outbreak of foot-
and-mouth disease (FMD) in Greece during 1994. This epidemic suggested that
under certain circumstances transmission of foot-and-mouth disease virus (FMDV)
may not be as efficient as is classically thought. Here, analysis of field data from the
epidemic has shown that conditions at the source of the epidemic may have provided
an initial amplification of the force of infection, enabling the virus to cause a limited
number of outbreaks elsewhere. These favourable conditions included a high density
and large number of sheep flocks. Later in the epidemic, the distribution of sheep
flocks was more dispersed and led to an epidemic that was termed "self-limiting".
Seemingly, without the influence of control measures, the infection rate of FMDV
within sheep flocks fell dramatically until no cases of clinical FMD occurred. The
virus was not sheep-adapted.
Serial passage experiments described here have been designed to ensure a consistent
exposure period for sequential groups of sheep, such that each group was exposed to
the same proportion of the previous group's total excretion. Two identical
experiments were performed with four groups of sheep. Serial passage of this isolate
showed a significant reduction in the viral load of infected animals after passage of
virus through two groups of contact infected sheep. This reduction corresponds with
a decrease in the estimated force of infection. Transmission of this isolate through
contact infected sheep failed to amplify or maintain the level and force of infection.
Virological factors contributing to "self-limitation" have also been investigated.
Experiments described here show that dose-dependent transmission of this isolate is
a complicated process. Immunologically, inoculated sheep responded well to this
isolate, such that with higher doses immune mechanisms reduced the infectiousness
of inoculated animals. Sheep inoculated with the highest dose of virus did not
transmit infection to in-contact animals. Above the threshold dose for infection there
was a decline in the infectiousness of inoculated animals and a corresponding
reduction in the level of infection for in-contact animals. Principal component
analysis of infection parameters for inoculated animals shows that characteristics of
infection group well with dose.
The results of the experiments described here suggest that isolates of FMD that are
not adapted to sheep may be unable to maintain themselves in sheep populations.
FMDV in cattle and pigs transmits rapidly and has the potential to create
concentrated foci of infection. The potentially different behavior of FMDV in sheep
should be carefully considered when attempting to control FMD epidemics.
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Foot-and-mouth disease (FMD) is a highly contagious viral disease of cattle, sheep,
goats, pigs and wild ruminants. Infection of a wide range of species including impala,
red kangaroos, wombats, hedgehogs, coypu, water voles, moles, agouti, some species of
deer and rarely man has been demonstrated.
1.1.1 Foot-and-mouth disease virus
Foot-and-mouth disease virus (FMDV), of the family Picornaviridae, is a member of the
aphthoviridae genus. There are seven serotypes O, A, C, SAT (South African
Territories) 1, SAT 2, SAT 3 and Asia 1. Within each serotype there is a large range of
antigenically distinct strains. Types O, A and C are the most widely distributed of the
seven serotypes. SAT 1, SAT 2, and SAT 3 are restricted to Africa although SAT 1 and
SAT 2 have occasionally spread to the Middle East. Asia 1 has been restricted to Asia
with a recent incursion into Greece (2000).
FMDV is an icosahedral, non-enveloped virus with a diameter of 28nm. The virus is
extremely pH sensitive with a very narrow stability range, the virus being quickly
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inactivated outside the pH range of 6.0-9.0. The capsid is made up of 60 protomers each
made up of one copy of the four viral proteins (VP1, VP2, VP3 and VP4) and surrounds
a single strand of RNA approximately 8.45 kilo-bases in length with a molecular mass
of 2.8x106 Da. The surface of the virion is relatively smooth compared to other
picornaviruses, having no canyons or pits although the surface of VP 1 has a number of
loops (Acharya et al., 1989) which are thought to be essential for cell attachment
(Strohmaier et al., 1982). VP4 is completely internalised.
Attached to the 5' end of the viral genome is a small virus basic glycoprotein (VPg) in
place of the methylated cap present in eukaryotic mRNA. The FMDV genome is divided
into four distinct regions. The first region (about 400 bases) from the 5' terminus is
known as the S fragment. Formation of a hairpin loop within this segment has been
predicted and may be involved with RNA replication (Belsham, 1993). The second
region consists of a homopolymeric tract of cytidyl residues termed the poly C tract
whose function is unknown. Following the poly C tract there is a non-coding region
(about 720 bases) which contains the internal ribosome entry sequence (IRES) and has
been predicted to form a number of pseudoknots whose function is also unknown. The
FMDV IRES directs cap-independent initiation of protein synthesis and is highly
conserved among FMDV isolates. The majority of the genome consists of a single, large
open reading frame that in type O viruses is 6996 nucleotides long and encodes for a
single polyprotein. In common with other picornaviruses, FMDV has a poly-adenosine
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tail at the 3' end. The single large polyprotein is cleaved by viral proteases to form
structural and non-structural proteins after translation of viral RNA. The virus has
associated RNA polymerase, for replication, and protein kinase for phosphorylation of
structural proteins.
For type Oi strains of FMDV five neutralising antibody sites have been characterised
(Kitson et al., 1990; Crowther et al., 1993). Two of these sites, including the major site
A within the G-H loop, form part of VP1. The function of site A as the
immunodominant antigenic site has been tested in pigs where varying degrees of
immunodominance were found (Mateu et al., 1995). Antigenic epitopes on the surface
of the virion can be screened using panels of monoclonal antibodies. Such methods
enable characterisation of strains ofFMDV into subtypes (Crowther, 1986).
VP1 is the only structural protein capable of inducing a serotype specific neutralising
antibody response (Bachrach et al., 1975) and when administered alone can confer
protection to challenge by homologous virus (Crowther, 1986). Despite this, FMDV
sub-units containing VP1, as well as VP2 and VP3, are not as immunogenic as 146S
whole particles which are essential for a successful vaccine (Crowther, 1986).
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1.1.2 History
FMD was first described by Fracastorious (1545) in Northern Italy. FMD was recorded
in Germany in 1751 and quickly spread throughout Europe. A major breakthrough in the
understanding of FMD came in 1898 when the causative agent was discovered to be a
virus (Loeffler & Frosch, 1898). FMD is one of the most economically important
diseases of livestock. The outbreak in Great Britain during 1967-8 resulted in
compensation in excess of £35 million (Anon, 1978). The disease reached Britain in
1839 and there followed a succession of outbreaks, which resulted in the disease being
made notifiable in 1871. The difficulty in controlling the disease was mainly due to a
poor understanding of the epidemiology of FMD. For example, it is thought that the
spread of FMD between farms by visitors facilitated a major epidemic in America
between 1915 and 1916. In 1922, Vallee and Carre demonstrated there were antigenic
variants of FMDV and named them Oise (O) and Allemange (A). Type C was
discovered in 1926 and SAT 1-3 in 1948. Asia 1 was not recognised until 1954.
FMD is endemic in countries situated in Africa, the middle and far east, Asia and South
America. Australia, USA, Canada and Scandinavia are all free of FMD. The majority
of continental Europe is also free ofFMD although there are occasional outbreaks in the
countries of southern and eastern Europe (Kitching, 1998). The adoption of a non-
vaccination policy by the European Union (EU) in 1991 has created a livestock
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population that is completely susceptible to FMD. Since implementation of the non-
vaccination policy outbreaks of FMD have occurred within the EU (Italy, 1993; Greece,
1994, 1996 and 2000; Great Britain, France and Holland, 2001). The possibility of
vaccinated cattle developing persistent infection following contact with field virus
during an outbreak ensures there will be a continued reluctance to use vaccination in
favour of stamping out procedures. The EU remains at risk of FMD from the Middle
East, Eastern Europe and North Africa. Major outbreaks occurred in Britain in 1922,
1942, 1952, 1967 and recently in 2001. In 1967, the introduction of FMDV in infected
meat from Argentina resulted in 2364 outbreaks and the slaughter of almost half a
million animals (Hugh-Jones & Wright, 1970). Variation in price differentials could
lead to the incursion of FMD into the EU through illegal movements of infected
animals, particularly sheep and goats in which the disease is often mild or inapparent.
With the continued development of fast modern transport systems infected animals can
travel the entire length and breadth of the EU in two or three days.
1.1.3 Pathogenesis
Sheep are highly susceptible to FMDV infection through the respiratory route and breaks
in the epithelium. Although sheep and cattle have the same minimum infectious dose,
the threshold concentration of virus required to infect sheep is much higher due to the
lower inhalation rate (Sorenson et al., 2000). After virus has entered the host, primary
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replication occurs at the site of entry, particularly the upper respiratory tract and pharynx
(Burrows et al., 1981). Following initial replication there is dissemination of virus to
other areas of the body. Although virus has been detected in sites of predilection prior to
the onset of viraemia (Brown et al., 1992) transport of virus via the bloodstream no
doubt plays an active role in spread within the body. It has been postulated that the
occurrence of vesicular lesions in the absence of viraemia could represent local infection
through abrasions in the epithelium (McVicar & Sutmoller, 1972). Sites of predilection
include the epithelia of the oral cavity, coronary band and interdigital space and the
mucosa of the pharynx (Burrows et al., 1981).
Three serotypes of type C FMDV utilise a common receptor on bovine kidney cells
(Baxt & Bachrach, 1980) and monoclonal antibodies against viral surface receptors can
block binding of other picornaviruses (Shepley et al., 1988). The conserved arginine-
glycine-aspartic acid (RGD) sequence on the loop of VP1 is a motif used by many
viruses to attach to the integrin molecules on mucosal epithelial cells (Bai et al., 1994,
Roivainen et al., 1994). Enzymatic digestion of the RGD region of VP1 (residues 133-
158) inhibits attachment of FMDV to certain cell lines (Strohmaier et al., 1982). FMDV
has been shown to be capable of binding to heparan sulphate on the surface of cells
(Jackson et al., 1996) although this is thought to be a consequence of tissue culture
adaptation (Sa-Carvalho et al., 1997). FMDV utilises the ayp3 integrin as a primary
receptor (Neff et al., 1998).
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1.1.4 Diagnosis
Diagnosis of FMD is based on the recognition of clinical signs, virus isolation and
antigen detection. Seroconversion, where there is no history of vaccination, can also
serve as an indicator of infection (Hamblin et al., 1986). ELISA testing has replaced
complement fixation and virus neutralisation tests in the laboratory diagnosis of FMD.
ELISA tests are commercially available for the detection of FMDV antigens and
antibodies against FMDV (Ferris and Dawson, 1988). Field samples (epithelium or
blood) from suspect animals, can be tested for infection against all seven serotypes and
several strains. If the initial sample does not contain sufficient viral material then
samples can be amplified in tissue culture e.g. primary bovine thyroid cells (BTY) or a
continuous swine kidney (IB-RS2) cell line.
1.1.4.1 RT-PCR as a diagnostic tool
The use of reverse transcription polymerase chain reaction (RT-PCR) as a diagnostic
tool to detect and serotype subclinical FMD has been investigated (Reid et al., 1998;
Vangrysperre & De Clerq, 1996). To increase the sensitivity of RT-PCR assays above
that of virus isolation a second PCR step is needed. Nested PCR (RT-nPCR) has been
shown to have a sensitivity greater than virus isolation (Forsyth et al., 1998) and plaque
testing (Moss & Haas, 1999) but also has a higher risk of contamination leading to false
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positive results (Erlich et al., 1991). Reid et al. (1998) advised that RT-PCR for the
routine diagnosis of FMD should be in addition to the conventional methods already in
use as PCR methods sometimes fail to diagnose samples that show positive results by
virus isolation.
RT-PCR to detect FMDV RNA in various secretions and tissue samples, including
oesophageal-pharyngeal fluid (OPF) (Moss & Haas, 1999), throat swabs (Callens et al.,
1998) and nasal swabs (Forsyth et al., 1998; Moss & Haas, 1999) has yielded varying
results. From nasal swabs, RT-nPCR is able to detect viral RNA prior to the onset of
clinical signs (Moss & Haas, 1999). Detection of digoxigenin labelled PCR amplicons
by ELISA (RT-PCR-ELISA) increases the sensitivity of tests (Forsythet al., 1998). RT-
PCR-ELISA on throat swabs taken from experimental sheep has been shown to detect
subclinical infection of in-contact sheep (Callens et al., 1998). Inhibitors of reverse
transcription and PCR within sample fluid (Moss & Haas, 1999) and the intermittent
detection of virus in OPF (Doel et al., 1994) may limit the use of RT-nPCR on probang
samples. Conversely, for the detection of persistent infection, probang samples have
been shown to be more reliable than nasal swabs (Forsyth et al., 1998). The variable
detection rates of viral RNA in both throat swabs (Callens et al., 1998) and OPF (Moss
& Haas, 1999) suggests that reliable diagnosis of infected and persistently infected
animals may require continuous sampling regimes. Recently, a quantitative RT-PCR
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method has been successfully applied to measure the levels of FMDV in various porcine
tissues following infection (Oleksiewicz et al., 2001).
1.1.5 Control
For successful international trade of livestock, movements of live animals and animal
products must follow the guidelines of the Office International des Epizooties (OIE)
code. Effective control of outbreaks is through measures such as slaughter of infected,
in-contact and seropositive animals, coupled with stringent movement and other
zoosanitary policies. These measures remain the most effective mechanisms in
restricting spread of FMD. Since the realisation that wind borne virus could prove an
important factor in FMD outbreaks, a computer programme has been developed to
model the effects meteorological conditions can have on an epidemic (Donaldson,
1988). This allows ring vaccination to be planned around the area predicted to be
affected. Ring vaccination strategies aim to reduce susceptible animals around a primary
outbreak. Strategies of this type have a number of problems inherent with their
implementation. These include restrictions on the movement of vaccinated animals from
within the ring zone, loss of export from within the region and the risk of fomite
transmission originating from infected vaccinated animals (Donaldson & Doel, 1992).
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1.1.6 Vaccination
Vaccination against FMD is determined by regional or national control policies. Since
1991, the European Union has adopted a non-vaccination policy in an attempt to allow
greater movement of livestock within the Single Market (Directive 90/423/EEC). The
decision to cease vaccination within the EU also followed evidence that improper
inactivation of vaccine virus had led to a number of outbreaks in Europe during the
1980s (Beck & Strohmaier, 1987). However, the option to vaccinate is retained should
other control measures prove ineffective, and emergency antigen banks are available
should an EU country require vaccine. Immunisation against one serotype of FMDV
does not confer resistance against others. Emergency vaccines should induce a very early
protective immune response as well as having a broad antigenic spectrum.
1.1.6.1 Response of sheep to immunisation
Emergency vaccination has been shown to protect cattle from airborne challenge
between 2 and 4 days post immunisation (Doel et al., 1994, Salt et al., 1994), pigs
within 4 days of immunisation (Salt et al., 1998) and sheep within 4 days of
immunisation (Cox et al., 1999). In cattle, early humoral responses are similar to those
seen in natural infection but the peak titres of IgM, IgGi and IgG2 are delayed with a
reduced titre and avidity (Abu Elzein & Crowther, 1981). Immunisation of sheep with
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inactivated whole virus particles (146S) protects against clinical disease and has been
shown to elicit a local neutralising antibody response in the respiratory tract of
vaccinated sheep, and may reduce the duration of excretion (Cox et al., 1999; Gibson et
al., 1984; Sellers et al., 1977). Sheep are vaccinated with a third or a half of the bovine
dose with conventional saponin aluminium hydroxide-inactivated vaccine. Responses to
inactivated vaccines have been shown to be antigen dose related (Pay & Hingley, 1987).
Vaccination can induce protection from challenge for 3-6 months (Panina, 1990).
Primary courses of vaccine are given in the form of two inoculations within 3-4 weeks
with the use of booster doses depending on the potency of the vaccine used. Sheep show
good serological responses to such booster doses (Pay, 1988). In endemic areas,
particularly those with a high density of susceptible animals, such as farms in Saudi
Arabia and Israel, vaccination of cattle can take place up to five times a year.
1.1.7 Foot-and-mouth disease in sheep
Although sheep represent the major proportion of the world's FMD susceptible livestock
(Anon, 1993) studies on the nature of the disease in small ruminants remain limited.
Sheep and goats are often overlooked as a potential source of FMD dissemination
(Panina, 1990) despite experimental evidence to the contrary (Gibson & Donaldson,
1986). The effects of the disease are often mild or inapparent and easily missed by the
farmer or veterinarian. Geering (1967) concluded that unless there was suspicion of
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FMD and careful examination, the disease would go undetected. It is generally accepted
that naturally acquired infection of FMD is milder in small ruminants than in cattle and
pigs. One set of findings showed, using serology, that 27% of experimentally infected
sheep failed to develop lesions (Gibson et al., 1984). To ensure the regular occurrence of
viraemia in infected sheep, serial passage was shown to be required for one isolate of
FMDV (Fontaine et al., 1966).
The incubation period for natural infection is normally between 3 and 8 days (Kitching
& Mackay, 1994) but can be less than 24 hours following experimental inoculation
(Sellers et al., 1977). The first sign of infection within a susceptible flock is lameness,
which develops quickly and spreads. The feet of affected animals are hot and painful
when handled. In severe cases classic signs of FMD are seen: lassitude, anorexia, fever
and vesicle formation. Foot lesions in sheep are more common than oral lesions and
occur in the interdigital cleft, on the coronary band and on the bulb of the heels (Pay,
1988). If mouth lesions do occur they are transient, and quickly heal. Lesions may also
occur on the gums, hard palate, lips and tongue. The serotype and strain of virus has
been shown to influence the virulence of disease in sheep (see Pay, 1988). The mortality
rate in ovine epidemics is normally negligible for adult animals and a figure of 0.38%
has been recorded for an outbreak amongst sheep in Turkey during 1963 (Pay, 1988).
Infection of lambs is normally without vesicles but mortality can reach up to 100% due
to myocarditis (Chevskii et al., 1964).
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1.2 Host immune responses to foot-and-mouth disease virus
If a virus is successful in evading non-specific host immune defences such as physical
barriers, non-specific phagocytes and natural killer cells, then it encounters specific
immune responses. Picornavirus immunity is led by an isotype-specific antibody
response, the levels of virus specific antibody correlating well with clearance and
recovery from infection.
1.2.1 Serum antibody responses
Infection of susceptible cattle induces an antibody response with early IgM production
(around 3.5 days post-infection) which peaks at 10 days post infection. The onset of
seroconversion coincides with the cessation of viraemia and a reduction in excretion
(Cox et al., 1999; Gibson et al., 1984). Early IgM production is followed by an isotype
switch to IgGi between four and seven days post-infection with smaller amounts of IgG2
and IgA also detectable (Abu Elzein & Crowther, 1981; Brown et al., 1964). Cuncliffe
(1964) detected neutralising antibody in infected cattle for up to 4.5 years. Several cattle
from the study resisted challenge with homologous and heterologous virus 11 months
after infection.
13
Subcutaneous injection of sheep with FMDV produces virus specific antibodies within 3
days, which rise to a peak after 10 days. Between 10 and 35 days the levels decrease and
plateau for around 150 days (Panina, 1990). Exposure to virus produces detectable
antibody within 5 days (Dellers & Hyde, 1964). Production of large amounts of antibody
corresponds to the onset of clinical signs, a reduction in excretion and a cessation of
viraemia. Serum antibody produced by infected sheep provides protection against
challenge from homologous virus for up to 1.5 years.
Antibody mediated clearance of virus is accepted as the major immunological response
to FMDV (McCullough et al., 1992). The IgGi titre appears to be crucial for a
successful immune response (Mulcahy et al., 1990). Both total serum antibody and
levels of IgGi correlate well with recovery from FMDV infection (Salt, 1993b). Serum
IgG may prevent the spread of virus to potential sites of persistence in the infected
animal. For animals with high serum antibody levels virus may persist in the pharynx or
utilise a cell-associated transport system to pass throughout the body unhindered (Brown
et al., 1992).
1.2.2 Secretory antibody responses
In response to viral infection of tissues of the respiratory system, specific secretory and
serum antibody responses are produced (Welliver & Ogra, 1988). The ruminant mucosal
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immune system, responsible for large secretory antibody production, has been shown to
be similar to other mammalian species (Husband, 1987). Mucosal antibodies are
predominantly IgA, levels of which are greater than all other isotypes of
immunoglobulin combined (Mazanec et al., 1993). The bronchus associated lymphoid
tissue (BALT) includes specialised cells that take up and transport antigen (McGhee et
al., 1992). Induction of a good immune response requires large amounts of antigen
present at the site of infection to aid the expansion of B-cells into isotype specific
plasma cells. The stimulated B and T lymphoblasts then enter circulation and target
infected tissues. Terminal differentiation occurs within the local microenvironment.
BALT activation by antigen induces stimulation and dissemination of B- and T-cells to
infected mucosal sites (McGhee et al., 1992). Secretory antibody responses are isotype-
specific (Heckert et al., 1991) and in a number of viral infections immunity to infection
correlates to the titre of the secretory antibody response (Welliver & Ogra, 1988).
During FMDV infection a secretory response can last up to five months post-infection
and is predominantly local secretory IgA (Matsumoto el al., 1978). The lymphoid tissue
of the mucosa contains memory and virgin cells for the production of IgA (McGhee et
al., 1992). Scicchitano et al. (1986) found that 95% of IgA in the upper respiratory tract
of sheep was mucosa derived, levels being approximately 25 times those in plasma.
Serum derived antibody can be selectively transported to the infected epithelium
whereas IgA is produced locally within the mucosa as dimeric secretory IgA (Butler,
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1986). Levels of IgG become at least equal to those of IgA in the lower regions such as
the bronchi and alveoli (Welliver & Ogra, 1988).
Experimental observations have shown animals persistently infected with FMDV to
produce a longer secretory antibody response (Matsumoto et al., 1978). Convalescent
carrier animals show marked resistance to viral replication in the pharynx where IgA
responses are high (Salt, 1993b). Antigen specific IgA, when extracted from the
respiratory secretions of cattle, has been shown to neutralise FMDV in vitro. It is
unknown whether IgA actively protects against subsequent homologous infection or
whether a related arm of the local immune system plays a contributory role in clearance.
Garland (1974) found that secretory antibody produced by previous vaccination, could
reduce the titre ofFMDV in OPF. Cattle with established carrier status have shown both
high serum antibody titres to FMDV antigens (McVicar & Sutmoller, 1974) and non-
detectable levels (Hedger, 1968) indicating there is considerable individual variation.
Salt (1993a) found no discernible differences in the titres of secretory IgA between cattle
that had successfully cleared infection and those that developed persistence. Pigs
produce a serum response very similar in profile to that of the secretory one (Francis &
Black, 1983) and do not develop into carriers ofFMDV.
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1.2.3 Role of cytotoxic T-cells and cell mediated immunity
Despite the correlation of recovery from infection with serum antibody production, there
are recorded anomalies that suggest there is a role for cellular arms of the immune
system in immunity to FMDV. During potency testing of virus vaccine, some animals,
with seemingly protective antibody titres, remain susceptible whilst others with almost
non-detectable levels following vaccination resist challenge with live virus (Sigal et al.,
1992). Animals viraemic for FMDV have also been shown to clear infection without
seroconversion (Donaldson & Kitching, 1989). The poor protection produced with
peptide vaccines could be due to a failure to correctly induce antibody production or a
failure to activate necessary arms of the cellular immune system, or both (Collen, 1994).
The role of specific cellular immune mechanisms in immunity to FMDV is largely
unknown. Cytotoxic T-lymphocytes have been implicated as the more active component
of the immune system in combating persistent viral infections (Oldstone, 1991) although
expression of surface proteins during persistent infection is minimal (Oldstone, 1991)
and such mechanisms have been previously discounted in immunity to FMDV
(McCullough et al., 1987). Recently, CD8+ T-cell responses following experimental
infection with FMDV have only been detectable after the acute stage of infection
(Childerstone et al., 1999).
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Cell-mediated immune mechanisms can act upon cells expressing very small amounts of
antigen on their surface (Demotz et al., 1990) and can destroy infected cells during the
latent phase of infection (Oldstone, 1991). Proteolytic viral epitopes (5-9 amino acids)
are presented on the surface of infected cells and recognised by CD8+ T-cells, via MHC
class I expression, and by CD4+ T-cells, via MHC class II expression. Elaboration of
cytokines selecting for a T-helper cell type 1 (Thl) response, such as IFN-y and IL-2,
leads to activation of cellular arms of the immune system and intracellular killing
through macrophage activation. Amadori et al. (1992) found that IL-2 and IFN-y
correlated well with successful immunity to FMD in cattle. The saliva and nasal fluid of
cattle possessing anti-viral activity, in the acute stage of FMD infection, has been shown
to contain IFN-y. There is limited evidence of a Thl type response in FMDV infected
guinea pigs (Knudsen et al., 1979) and buffalo (Sharma et al., 1985). NK cells, large
producers of IFN-y, have been shown to influence the regulation of T-helper cell
differentiation and such an activity has been described in FMDV infected cells (Amadori
et al., 1992). Although there are clear divisions in the cytokines responsible for the
Thl/Th2 dichotomy in vitro the situation remains unclear in vivo. Thl and Th2
responses are cross regulatory (Scott, 1993) and a number of human and mouse clones
have been shown to co-express both Thl and Th2 cytokines (Wood & Seow, 1996). The
factors leading to differentiation of naive CD4+ T-cells remains unclear. In some animal
models the epitopes present on the antigen presenting cell have no effect on the
proliferation to either a Thl or Th2 type response but in vitro studies have demonstrated
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otherwise (Scott, 1993). The antigen dose has been demonstrated to influence this
dichotomy. At present it is unknown which factors determine levels of regulatory
cytokines in FMD infection.
1.2.4 Neutralisation and clearance of virus
Neutralisation of FMDV in vivo is antibody mediated and potentially utilises a number
ofmechanisms. McCullough et al. (1987) demonstrated that monoclonal antibodies to a
type O FMDV could induce conformational change in the capsid that neutralised greater
than 99% of virus due to loss of the RNA genome and formation of unstable capsids.
Aggregation of virus, prevention of viral uncoating and destabilisation of the capsid
(Mason et al., 1993) can also neutralise virus in vivo. Clearance of FMDV in the mouse
model is reduced when either the Fc portion of the specific antibody or the macrophage
system is absent (McCullough et al., 1990). For successful clearance of virus,
phagocytosis is assisted by antibody-dependent opsonisation of virus. During FMDV
infection it has been shown that in the absence of phagocytosis, antibody-virus
complexes are still infectious (McCullough et al., 1992).
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1.3 Persistence and the carrier state
Persistent infection may develop following immune failure to clear virus at the acute
stage of infection. This situation is common for many picornavirus infections including
poliovirus, Theiler's virus and echovirus 6 (Borzakian et al., 1992). For a lytic virus
such as FMDV to persist within an immunologically uncompromised host, replication
must occur in non-lytic cycles with suppression of immune responses. This pressure may
select for variants which utilise one of two recognised mechanisms for the development
of persistence: expression of a non-lytic phenotype (or development of a non-lytic phase
of viral replication) or diminished viral gene expression through interaction of viral and
cellular transcription factors (Oldstone, 1991). Persistent virus in tissue culture can take
one of four forms (Mahy, 1985): steady state viruses (cells infected with a non-lytic
virus), carrier culture virus (lytic virus replicating at a very low rate), virus showing
intra-cytoplasmic persistence (immature uninfectious virus passes from cell to cell) and
latent virus (transcription of viral genome is severely restricted). The implications and
classification of these classes in vivo is unclear.
Persistent FMDV infection is suspected as the cause of a number of outbreaks of FMD
including the 1922 UK epidemic (Pledger & Stubbins, 1971) and the introduction of
FMD into Mexico from Brazil in the 1940s (Van Bekkum, 1973). Van Bekkum et al.
(1959) demonstrated carrier status under experimental conditions when virus was
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detected in samples from experimental cattle up to 5 months post-infection. For FMD a
carrier is classified as any animal where virus can be isolated after 28 days post-infection
(Sutmoller et al., 1968). Carrier animals of FMDV develop following infection and
virus persists in the pharynx (cattle) and tonsillar region (sheep) (Burrows, 1968b).
Detection of persistent infection uses the probang 'sampling cup' to extract OPF for
virus isolation. Virus detection is intermittent and sampling techniques produce
inconsistent results. Virus is not found in the saliva of carrier cattle (Wittman & Eissner,
1966) suggesting that mucus and cellular material are the critical components of OPF for
virus recovery. Experimental studies have shown that sheep can become carriers of
FMDV following exposure to infected cattle, sheep or pigs (Burrows, 1968b; Fondevila
et al., 1996; McVicar & Sutmoller, 1968) and virus may be recovered from OPF for up
to 9 months post infection (McVicar & Sutmoller, 1968).
1.3.1 Methods of persistence
1.3.1.1 Ineffectual immune response
For cattle the immune status (vaccinated, passively immunised or naive) of the animal
has no influence on the probability of development of a persistent infection following
contact with live virus (Burrows, 1966) although Salt (1993b) found a marginally greater
incidence amongst non-vaccinated cattle. Field evidence shows that the probability of
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detecting carriers of FMDV increases if the FMDV-specific serum antibody titre of the
herd or flock is high (McVicar & Sutmoller, 1974), despite evidence from experimental
animals which shows no such relationship (Hedger, 1970; Van Bekkum, 1973).
Vaccination reduces the frequency of clinical cases, raising levels of immunity and
therefore reducing levels of FMDV in the environment and the potential of new carriers
developing (Anderson et al., 1976). Cattle herds with low mean serum neutralising
antibody titres are unlikely to harbour carriers (Hedger, 1970).
The early IgGi peak in cattle may be responsible for clearance of virus from the pharynx
due to efficient uptake of IgGi complexed virus by macrophages (Salt, 1993b). Large
amounts of slgA produced by mucosal tissues may restrict the spread of FMDV to the
bloodstream. Resistance to reinfection has been shown to correlate with a persistent
infection of homologous virus (McVicar & Sutmoller, 1974) and the presence of IgA in
secretory fluids (Salt, 1993b). There is no evidence of a failure to elicit local or systemic
immune responses in persistent infection with FMDV.
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1.3.1.2 Persistence in privileged sites
Persistent viral infection can occur at immunologically privileged sites. Epithelium lined
secretory cells are known sites of persistence for immune evading viruses of vertebrates
(Mims, 1988). These cells face into a lumen which is outside the body and from which
virus can be released without cytolysis (Salt, 1998). Other frequently used sites for viral
persistence are cellular elements of the immune system (monocyte/macrophage lineage)
(Oldstone, 1991) but there is a lack of evidence linking this method to FMDV
persistence. FMDV immune complexes have been shown to infect pig macrophages
(Baxt & Mason, 1993). Yilma (1980) implicated mononuclear cells as a possible
privileged site for FMDV in the pre-viraemic stages of infection and as a potential
transport system for virus although this has not been proven.
1.3.1.3 Trans-encapsidation with bovine enterovirus
FMDV has been seen encapsulated with the coat protein of bovine enterovirus (BEV) in
vitro (Trautman & Sutmoller, 1971) and in vivo (Graves et al., 1971). It has been
suggested that encapsulation could stimulate a low level localised, non-specific immune
response sufficient to prevent the spread of FMDV but too small to bring about a
destructive immune response (Sutmoller et ah, 1970). There is no evidence from carrier
studies to support this hypothesis.
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1.3.1.4 Defective interfering particles
Persistent infection by a lytic virus can develop through the formation of replication
defective genomes which become incorporated into defective interfering particles (DIPs)
or viruses (DIVs). DIPs exist as a separate population within an infected host, dependent
on the homologous parental virus for replication and causing disruption to the biology of
the host-parasite relationship. This method is employed successfully by paramyxoviruses
and rhabdoviruses. DIP's have been observed for almost every virus, including members
of the pircornaviridae. Non-infectious FMDV RNA fragment production has been
demonstrated at the latter stage of persistent infections in vivo and in vitro (de la Torre et
al., 1985; Rossi et al., 1988). The role ofDIP's in FMDV persistence is unclear.
1.3.1.5. Antigenic variation
Through variation in antigenic make-up, viruses may persist by avoiding specific
immune responses. Antigenic variance of FMDV is thought to occur at rates similar to
other RNA viruses (McCahon, 1986) as a result of point-mutations caused by errors in
copying of the genome and recombination events between FMDV genomes present in
the same cell (Domingo et al., 1985; Fellowes & Sutmoller, 1970). The mutation rate
has been estimated at between 10"3 to 10"4 base pairs per replication (Smith & Inglis,
1987). Domingo et al. (1993) defined FMDV populations as quasispecies with the
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potential to undergo rapid antigenic change. This has been shown to take place
irrespective of immune status (Domingo et al., 1993) but the selective pressure produced
by cellular and humoral arms of the immune system may provide an ideal environment
for the selection of variants. Antigenic drift is common in vitro and was first shown by
Hyslop (1965). Antigenic variation has been demonstrated in tissue culture (Diez et al.,
1990) and after only a single passage in pigs (Carrillo et al., 1990). In a state of
persistence large variations in antigenic structure (Fox et al., 1989) and, conversely,
antigenic stability in cattle (Vosloo et al., 1996) and sheep (Sharma et al., 1982) has
been shown to occur for FMDV.
Rowlands et al. (1983) found that serial passage of FMDV resulted in an alteration of
antigenicity through amino acid substitutions. Within an isolate of virus there is more
than one variant, leading to what has been termed a 'master' sequence with an a
equilibrium distribution of variant sequences (Domingo et al., 1985). Under selective
pressure from the immune system in vivo a virus population may under go antigenic drift
until a new master sequence becomes established (Domingo et al., 1990). Studies on
genome evolution in beef herds in Zimbabwe has shown that FMDV antigenic change is
very slow (Knowles & Bosch, 1990). This makes this method of persistence unlikely for
FMDV although antigenic variation may have implications for virulence, pathogenicity
and transmissibility (Haydon & Woolhouse, 1998).
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1.3.1.6 Attenuation of virulence
The high mutation rate for FMDV during replication creates a potential for genetic
alteration that may lead to a virus population capable of invading host cells and
producing little or no cytopathic effect. The scope of genetic variation has been
demonstrated in vitro for FMDV and co-evolved BHK cells where only nine fixed
amino acid substitutions resulted in significant phenotypic alteration (Diez et al., 1990).
Numerous strains of carrier virus have shown reduced virulence in homologous and
heterologous species (Burrows, 1966; Kaaden et al., 1970; Straver et al., 1970). Diez et
al. (1990) found a strain of FMDV which, after 100 passages through BHK cells,
showed high attenuation of virulence for mice and cattle.
The polyribocytidilic acid tract (poly C) of FMDV is a distinctive feature of the viral
genome. Located approximately 400 nucleotides from the 5' end of the RNA genome,
the tract is 100-300 nucleotides in length and has been investigated in attenuation
studies. During replication of FMDV the length of the poly C tract can vary (Zibert et
al., 1990) and heterogeneity of the tract has been linked to persistence of FMDV. In
tissue culture, alteration of the poly C tract corresponds to attenuation (Costa Giomi et
al., 1984; Escarmis et al., 1992) and cattle isolates have been shown to exhibit a longer
poly C tract than the parental strain (Costa Giomi et al., 1988). Escarmis et al. (1992)
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suggested that deviation in the length of the non-coding region could lead to the
formation of a genetic lesion capable of interfering with host cell replication procedures.
1.4 Epidemiology of foot-and-mouth disease
FMDV can spread by a number of mechanisms of which the most common is direct
contact following animal movement. Disease can also be introduced through
contaminated animal products, fomites, vehicles, people, domestic or wild animals and
by airborne spread. The occurrence of secondary outbreaks is determined by a number of
factors including the species infected, species in-contact, local density of livestock,
movement patterns, the number of effective contacts between infected and in-contact
susceptible animals, speed of diagnosis and the efficiency of control measures.
Spread of FMD over large distances is possible through the generation of large plumes
of virus excreted by infected animals. Pigs are by far the most significant species with
regard to airborne spread of FMDV. The total excretion from one infected pig is
equivalent to that of 3000 infected cattle (Sellers, 1971). The risk of spread of FMD by
airborne virus from the continent has risen with the recent increase in the size and
density of pig herds in the Benelux countries and northern France (Donaldson & Doel,
1992). Historically, it has been suggested that outbreaks of FMD in Great Britain have
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been caused by spread of airborne virus across the channel when meteorological
conditions have proved favourable (Donaldson et al., 1982; Gloster et al., 1982).
1.4.1 The role of sheep in epidemics
Infectious sheep are a potential source of FMDV with infection of susceptible sheep
occurring following exposure to as little as ten infectious units (Gibson & Donaldson,
1986). This dose-dependent response is also strain-dependent. In 1972, sheep and goats
were recognised as a frequently inapparent source of spread and recommendations were
made to include prophylactic vaccination of sheep in vaccine campaigns (Pay, 1988).
The large population of small ruminants in North Africa and the Middle East has created
a reservoir for FMDV. The threat of incursions of disease to surrounding FMD free
areas is constant. Outbreaks of FMD with a predilection for sheep occurred in North
Africa between 1989 and 1992 (Mackay, 1994) and in the Middle East during 1996
(Taylor & Tufan, 1996). Outbreaks involving large numbers of small ruminants occurred
in Turkey during 1995 and 1996 and Greece in 1994 and 1996 (Kitching, 1998).
Recently, the outbreak of type O FMDV in Great Britain predominantly affected sheep
flocks. Serological surveys were undertaken following the outbreaks in Morocco
(Mackay, 1994; Mackay & Rendle, 1996) and Greece (Mackay et al., 1995). The results
of these surveys revealed a low level of seroconversion within sheep flocks towards the
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end of the epizootic. This low-level seroconversion followed an initial period of highly
transmissible clinical disease. In Morocco, vaccination, through an increase in the level
of herd immunity, seemed to reduce the spread of infection whereas slaughter of
seropositive animals had no impact on subsequent transmission. This may be due to the
fact that following the onset of seroconversion sheep are no longer infectious. Thus the
slaughter of seropositive animals will have no effect on the levels of circulating virus
although it will decrease the probability of carrier animals developing.
1.4.1.1 Excretion by infected sheep
Cattle, pigs and sheep infected with FMDV have been shown to excrete large amounts
of infectious virus (Donaldson et al., 1970; Sellers & Parker, 1969; Sellers, 1971). The
most common route of transmission of FMDV from sheep is through the production of
infectious droplets and aerosols excreted in the breath of sheep (Donaldson, 2000). In
some studies, detection methods have lacked the sensitivity necessary to accurately
quantify excretion (Sellers & Parker, 1969). In the two studies ofFMDV excretion using
infected sheep, the point of peak excretion was found between 24 and 0 hours prior to
the onset of vesicular lesions. FMDV has been isolated from infected sheep for up to
five days prior to the onset of clinical signs (Burrows, 1968a) but this has not been
correlated with infectiousness. Existing data for FMDV excretion by sheep was collated
for the EpiMAN-FMD epidemiological information system (Sanson et al., 1999) and
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has been adapted for atmospheric models to predict the airborne spread of FMDV
(Sorenson et al., 2000). The serotype and strain of virus has been shown to influence the
excretion profile of infected animals (Donaldson et al., 1970).
1.4.1.2 Sheep as maintenance hosts
Although there is substantial experimental evidence to suggest that carrier sheep are of
epidemiological importance, field evidence is scarce and to the contrary. With the
possible exception of a type O infection in a sheep flock in Brazil where within the same
flock new cases of clinical disease was recorded 2 months following the first case and a
number of sheep developed into carriers (Hancock & Prado, 1993). Interestingly, the
virus in Brazil showed a very high predilection for sheep. Studies in epidemic (Garland
et al., 1981) and endemic areas (Anderson et al., 1976) suggest small ruminant
populations are unable to maintain infectious virus for longer than the duration of the
period of clinical disease within the flock. Similar observations in Greece followed the
1994 epidemic where a period of subclinical transmission followed a period of clinical
disease. There were no further cases of clinical disease once the initial burst of
transmission ceased (Mackay et al., 1995). Field evidence from Saudi Arabia suggests
type O FMDV may continue to circulate within small ruminants with up to 40% of
animals subclinically infected (Farag et al., 1998). Similar observations have been
recorded for sheep and goat flocks in India (Shankar et al., 1998). Transmission from
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carrier animals (cattle or sheep) to susceptibles, despite numerous attempts, has not been
demonstrated experimentally. Titres of infectious virus from carrier cattle are low and
often below what is thought to be the necessary level required for transmission
(Donaldson & Kitching, 1989).
1.4.2 Species adaptation
Replication of FMDV within small ruminant hosts may result in an alteration of
virulence for both the small ruminant host and in-contact cattle and pigs. There are
numerous field reports of a variation in virulence of FMDV for different hosts.
Observations on pig adapted viruses in the field (Brooksby, 1950) have recently been
confirmed by experimental evidence of natural adaptation of an isolate ofFMDV to pigs
(Dunn & Donaldson, 1997). The most recent, and well-characterised, species adapted
virus is the type O virus that caused the hugely devastating epidemic in Taiwan during
1997 (Dunn & Donaldson, 1997). This virus was unable to cause generalised disease in
cattle and a deletion in the 3A non-structural protein and a number of surrounding point
mutations have been shown to be the major genetic determinants of the altered host
range of this virus both in vitro and in vivo (Beard & Mason, 2000). Field isolates from
the same area that have replicated within different host species has been shown to be
genetically different (Donaldson, 1998). Strains of type O FMDV with a predilection for
sheep were isolated from the outbreak of FMD in North Africa from 1989-1992. FMDV
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had maintained itself for 4 years, largely in small ruminants, exhibiting a very low
morbidity for cattle. In Morocco, the attack rate for sheep was 97% but only 0.3% for
cattle (Samuel et al., 1999). Studies on the receptors for FMDV have indicated that
receptor switching may be involved in adaptation of strains to different hosts (Neff et
al., 1998).
1.5 Molecular epidemiology
The genetic relationship between strains of FMDV can be compared using nucleotide
sequencing of the genome (Beck & Strohmaier, 1987). Although other viral proteins
contribute to the overall antigenicity of isolates (Kitson et al., 1990), VP1 phylogenetic
grouping does correlate with serotyping (Dopazo et al., 1988). This technique has been
used to study the molecular epidemiology and evolution of a wide range of isolates of
FMDV (Samuel et al., 1999). Nucleotide sequencing at the World Reference Laboratory
for FMD, Pirbright (WRL) has resulted in a database comprising over 1500 partial or
complete VP1 sequences of FMDV isolates (Kitching et al., 1989). Serotypes of FMDV
have been clustered together phylogenetically and divided into lineages of closely
related genotypes. When a genotype of FMDV exhibits geographical restriction they
have been termed topotypes. For type O FMDV there are 6 recognised topotypes
(Europe/South America, South Asia, South-East Asia, China/Hong Kong, East Africa
and Indonesia).
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1.6. Molecular evolution of foot-and-mouth disease virus
RNA viruses have a high mutation rate during copying of the genome due to the low
fidelity and lack of proof-reading activity of RNA polymerases (Domingo & Holland,
1994). The mutation rate of RNA viruses has been estimated as between 10'3 and 10"4
per single base site per replication cycle. The mutant progeny form a dynamic
distribution in sequence space termed the quasispecies (Domingo et al., 1999). This
spectrum of heterogeneous genotypes has a high potential adaptation to different
environments. Clones of FMDV exhibit varying fitness and heterogeneity of viral
populations has been found during acute infection (Carrillo et al., 1990). Selection for a
more transmissible variant does not assume selection of a more virulent variant. The
trade off between transmissibility, virulence and resistance may favour a reduction in
virulence through selection (Anderson & May, 1991). Reductions in viral fitness
through stochastic loss of the least mutated clones, known as Muller's ratchet, can occur
(Chao, 1990; Bergstrom et al., 1999). Alteration in the virulence of picornaviruses has
been seen to associate with a number of regions of the genome including capsid proteins
through altered interaction with cellular receptors (Samuel et al., 1990), the internal
ribosome entry site (Gromeier et al., 1999) and the poly C tract (Duke et al., 1990;
Escarmis et al., 1992). Positive selection of FMDV capsid proteins has recently been
shown to occur with field isolates (Haydon et al., 2001).
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1.7 Quantitative epidemiology
Simple mathematical models can be developed to estimate transmission rates after
introduction of a number of infectious individuals into a closed population of
susceptible animals. Such models make the assumption that the animal population is
homogenous and equally mixed i.e. each susceptible animal has equal contact with
infectious individuals. Estimations of transmission rates rely on the fundamental concept
of mathematical epidemiology that the course of an epidemic depends on the rate of
contact between susceptible and infectious individuals. This is the principle of mass-
action. The principle assumes there is a threshold density or number of susceptibles
below which an epidemic cannot maintain itself.
1.7.1 Basic reproduction numbers
Rates of transmission for infectious diseases can be measured using estimates of the
basic reproduction number (Ro). Ro is the number of new infections, or the average
number of secondary cases, caused by one infectious individual introduced into a
population of susceptible animals (Diekmann et al., 1990). For an infection to spread, Ro
must be greater than unity in value. Ro can also be estimated using a livestock unit (herd
or flock) as the epidemiological unit, in which case Ro is expressed as the ratio of
secondary outbreaks to primary outbreaks. Such a method has been successfully applied
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in estimation of Ro for FMDV epidemics among herds (Haydon et al., 1997). Movement
of individuals between disease classes can be modelled using differential equations
describing the rate of change for each class over time (Anderson and May, 1992). Each
equation is controlled by infection parameters. The rate that individuals become infected
is described as the force of infection (A) and can be estimated from experimental
transmission data.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Preparation of cell cultures
All virus isolation and titrations were performed using primary calf thyroid cells (BTY)
prepared fortnightly at the World Reference Laboratory for foot-and-mouth disease,
Pirbright (WRL). Bovine thyroid cultures were prepared from glands obtained from
young calves less than two months old which were trimmed of fat and rinsed twice in
100 ml of calcium and magnesium free phosphate buffered saline (PBS; see appendix).
Glands were then finely chopped and covered with Eagle's medium (see appendix) with
10% adult bovine serum and left overnight at 4°C. Chopped glands were washed three
times with PBS before addition of 100 ml of Dispase (neutral protease from Bacillus
polymixa, Grade II, Boehringer Mannheim) followed by stirring for 1 hour at 37°C to
dissociate the cells. Cell suspensions were then clarified at 1000 g for 10 min. This
process was repeated 2-3 times until all cells were thoroughly dissociated. Cells were
resuspended in Eagle's medium with 10% normal bovine serum, counted and diluted to
1x10s cells/ml. Cells were seeded in either flat sided tissue culture tubes (Nunc,
Denmark) or Falcon tissue culture flasks (Becton Dickinson Labware). After 4-5 days
growth at 37°C in Eagle's medium with 2% foetal calf serum, cells were transferred to
32°C. BTY tubes were ready for use within two weeks of preparation.
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2.2 Virus isolation and growth in bovine thyroid cells
Cell sheets were washed with 2 ml of PBS before addition of 200 pi of sample. Five
tubes were used for each sample tested. Tubes were then left at 37°C for 1 hour to
enable virus adsorption. Following incubation, cell sheets were washed three times with
2 ml of PBS and 2 ml Eagle's-HEPES (see appendix) medium added. Tubes were
returned to 37°C, placed on rollers and examined after 24 and 48 hours for evidence for
cytopathic effect (CPE). After clarification at 3000 g for 10 min all suspected positive
samples were confirmed as type O FMDV by antigen detection ELISA (as described in
section 2.4). If amplification of the titre of isolated virus was required, virus was passed
again in BTY cells by inoculation of cells with harvested tissue culture supernatant. An
adsorption step was not required for this procedure.
2.3 Virus titration in bovine thyroid cells
Five separate dilutions from a 10-fold dilution series were used for virus titrations.
Samples were diluted in M25 buffer (see appendix) and 200 pi added to each of four
BTY tubes as described in section 2.2. Titres were calculated as the Karber method
(Karber, 1931). Tissue culture infective dose 50 (TCID50) was calculated using the
following formula:
log TCID5(/ml = (log highest virus concentration) - total % CPE/100 - 0.5) + 0.7
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2.4 Antigen detection
Tissue culture supernatants were confirmed as containing FMDV type O by ELISA
(Ferris & Dawson, 1988). Nunc Maxisorp 96 well ELISA plates (Nunc, Denmark) were
coated overnight at 4°C with anti-FMDV type O hyperimmune rabbit serum (1:5000) in
coating buffer (0.05 M Na2CC>3, 0.05 M NaFlCCL; pH 9.6). Wells were washed three
times with PBS using a Denley platewasher before addition of 50 pi of sample and
positive controls. Plates were incubated at 37°C for 1 hour on an orbital shaker and
following incubation washed as before prior to addition of preblocked guinea-pig anti-
FMDV type O immune serum (1:1000 in blocking buffer; see appendix) and incubation
at 37°C on an orbital shaker. Following incubation, plates were washed as previously
before addition of horseradish-peroxidase (HRPO) conjugated rabbit immunoglobulin
anti guinea pig (1:200 in blocking buffer). Plates were returned to the orbital shaker at
37°C for 45 min, washed as before and an additional wash included which involved
flooding the plate with PBS to ensure all excess conjugate had been removed. Activated
substrate (Ophenylenediamine dihydrochloride (OPD) in phosphate-citrate buffer (pH
5.0) with 5% H2O2) was added to each well and all plates left for 15 min at room
temperature for colour to develop. Reactions were stopped by the addition of 50 pi of




Total serum antibody titres against FMDV type O were measured using a liquid phase
blocking ELISA (Hamblin et al., 1986). Duplicate two-fold dilution series of each serum
sample were incubated at 4°C overnight on an orbital shaker with an equal volume of
FMDV type Oi Manisa antigen (previously determined dilution in PBST; see appendix)
in 96-well U bottomed plates (Sterilin). ELISA plates (Nunc, Denmark) were coated
with FMDV type O specific hyperimmune rabbit serum (1:5000) in coating buffer (0.05
M Na2CC>3, 0.05 M NaHCCL; pH 9.6) and left overnight at room temperature in a humid
box. The following morning, coated plates were washed three times with PBS using a
Denley plate washer and 50 pi of test sample/antigen transferred to corresponding wells
on the coated plates. ELISA plates were then incubated at 37°C for 1 hour on an orbital
shaker. Following incubation, plates were washed three times with PBS and 50 pi
FMDV type O specific guinea pig serum added to each well (1:1000 in blocking buffer;
85% PBST, 10% normal bovine serum, 5% normal rabbit serum). Plates were returned
to the orbital shaker at 37°C for 1 hour. Following incubation, plates were washed as
before prior to addition of 50 pi of horseradish peroxidase conjugated rabbit anti-guinea
pig immunoglobulin to each well (1:1000 in blocking buffer). Plates were then returned
to the orbital shaker at 37°C for 1 hour. Following incubation, plates were washed as
before with an additional flooding of the plate with PBS to ensure excess conjugate was
removed. After incubation, 50 pi ofOPD with 5% H2O2 was added to each well and left
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for 15 min at room temperature for colour to develop. Reactions were stopped by the
addition of 50 pi of 1.25M H2SO4 to each well and optical densities read at 492 nm
using a Dynex MRX plate reader. All plates included strong and weak positive controls
(bovine serum), negative controls (normal bovine serum) and antigen controls (PBST).
Results were assessed as percentage inhibition of the mean of four antigen control wells.
From this, strict boundaries were set for the control samples (strong positive >85%
inhibition, weak positive between 50 and 85% inhibition, negative <40% inhibition). If
these control conditions were not met the plate was rejected and repeated. Antibody
titres were calculated as the reciprocal of the final dilution of serum that gave an OD
value of 50% of the mean antigen control. Mean antibody titres were calculated as
described in Thrusfield (1995). Geometric mean titres were calculated by back-
transformation of log2 transformed individual titres.
2.6 Oesophageal-pharyngeal samples
Oesophageal-pharyngeal fluid (OPF) was collected using the probang sampling cup
(Sutmoller & Gaggero, 1965). Samples collected from animals were immediately diluted
in the isolation unit with 5 ml of Eagle's-HEPES medium with 5% foetal calf serum. In
the laboratory, samples were immediately placed on ice before processing. 2.5 ml of the
diluted sample was added to 2.5 ml of Freon (1,1,2-trichloro-tirflourethane; Sigma). The
sample-Freon mix was vortexed for 2 min. The homogenate was then spun at 3000 g for
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10 min. Following separation the supernatant was carefully removed and 250 pi added
directly to 750 pi of TRIzol LS (Gibco, BRL) and 200 pi added to each of five BTY
tubes for virus isolation. The remaining volume of Freon treated OPF sample was stored
at -70°C.
2.7 RNA extraction
2.7.1 Throat swabs and probang samples
RNA was extracted using TRIzol and TRIzol LS (both Gibco, BRL) according to the
manufacturer's instructions. Throat swabs and TRIzol were transferred to a 2 ml skirted
Sarstedt tube using a sterile needle and 200 pi sterile PBS added to each tube followed
by 200 pi of chloroform. For probang samples, 250 pi of Freon treated sample was
added to 750 pi of TRIzol LS and vortexed. Following complete mixing, 200 pi of
chloroform was added. After addition of chloroform for both sample types, samples
were vortexed for 15 seconds, left at room temperature for 5 min and spun at 12000 g
for 15 min at 4°C. Following separation, 500 pi of the aqueous phase was transferred to
a 1.5 ml Eppendorf centrifuge tube containing 1 pi of glycogen and 500 pi of
isopropanol added. Samples were vortexed briefly and left at room temperature for 10
min to facilitate RNA precipitation. After centrifugation at 12000 g for 10 min at 4°C,
supernatants were aspirated and 1 ml of 70% ethanol added. Samples were vortexed
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briefly and centrifuged at 12000 g for 10 min at 4°C. Following centrifugation,
supernatants were aspirated and RNA pellets dried for 5 min at room temperature.
Pellets were redissolved in 20 pi of nuclease free water (Promega) by repeat pipetting
and stored immediately at -70°C.
2.7.2 Blood
Prior to the addition of chloroform, samples were vortexed for 20 seconds to ensure
complete homogenisation and spun at 12000 g for 15 min at 4°C. Following separation,
550 pi of the aqueous layer was removed into a fresh 2 ml Sarstedt and 200 pi of sterile
PBS added. 200 pi of chloroform was then added to each tube and RNA extracted as
described in section 2.7.1.
2.8 Reverse transcription
Five pi of extracted RNA was heated with 100 ng of random hexanucleotides
(Boehringer Mannheim) at 70°C for 5 min. After cooling at room temperature for 10
min, the primer template mixture was reverse transcribed at 37°C for 45 min in a 20 pi
reaction mix. The mix contained 50 mM Tris-HCl (pH 8.3), 75 mM KC1, 3 mM MgC^
(Gibco, BRL; supplied with reverse transcriptase), 0.5 mM (each) dNTP (Promega), 10
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mM dithiothreitol and 200 units ofMoloney-murine leukemia virus reverse transcriptase
(Gibco, BRL).
2.9 Nested polymerase chain reaction
Primers for both rounds of the PCR procedure had been previously designed (Forsyth et
ah, 1998) as complementary sequences to the highly conserved FMDV internal
ribosome entry site (IRES) and are shown in table 2.1.





Table 2.1. Oligonucleotide primers used for polymerase chain reaction
(PCR). All primers have been previously designed and used for detection of
type O FMDV (Forsyth ef a/., 1998).
First round, external primers used were IRES1 and IRES4 to give a 373bp DNA
product. For the internal nested PCR, primers used were and IRES3 and IRES4 giving a
196bp product.
A 5 pi RT reaction mix was amplified in a 50 pi total PCR reaction mix containing 20
mM Tris-HCl (pH 8.4), 50 mM KC1, 1.5 mM MgCl2, 0.2 mM (each) dNTP, 10 pmol of
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IRES 1 and IRES4 and 1 TaqBead Hot Start Polymerase wax bead containing 1.25 units
Taq DNA polymerase (all Gibco, BRL). Viral DNA was amplified using the following
thermocycler program: 94°C for 5 min, 1 cycle; 94°C for 1 min, 58°C for 1 min, 72°C
for 2 min, 30 cycles; 72°C for 7 min, 1 cycle. Amplification was performed using a
PTC-100 thermocycler machine (MJ Research Inc., USA). Second round nested PCR
was carried out under the same conditions using 5 pi of first round product as a template
and 10 pmol of each internal primer (IRES2 and IRES3). Nested PCR utilised the same
thermocycler program but for only 20 cycles. PCR products were visualised by
electrophoresis on a 1.5 % agarose gel stained with ethidium bromide (0.5pg/ml).
Product size was measured using a lOObp DNA ladder (Gibco, BRL).
2.10 Quantitative reverse transcription polymerase chain reaction
Quantification of viral loads was carried out using the GeneAmp 5700 sequence
detection system (Perkin-Elmer Biosystems). Viral RNA was extracted from whole
blood using TRIzol LS (as described in section 2.7) and reverse transcribed as described
in section 2.8. A 25 pi total reaction volume was used for PCR and reactions carried out
in MicroAmp optical 96-well reaction plates (Perkin-Elmer Biosystems). 24 pi ofmaster
mix was added to each well (5 pmol IRES1, 5 pmol IRES4, 12.5 pi 2xSYBR Green
PCR master mix (Perkin-Elmer Biosystems) and 8.5 pi nuclease free water (Promega))
and 1 pi of cDNA added. Plates were sealed using MicroAmp optical caps (Perkin-
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Elmer Biosystems) and mixed thoroughly before transfer to the thermocycler. Viral
DNA was amplified using the following program: 50°C for 2 min, 1 cycle; 95°C for 10
min, 1 cycle; 95°C for 15 seconds, 58°C for 30 seconds, 72°C for 1 min, 50 cycles.
Amplicon independent amplification was distinguished using dissociation curves
determined for each sample from 60-95°C. Quantification was determined against a
standard curve created using a 4-fold dilution series of cDNA from a known titre
sample. All plates were run with the standard dilution series (for generation of the
standard curve), eight separate negative controls (4 from FMDV negative blood
samples, 4 nuclease free water), 4 strong positive controls (RNA extracted from FMDV
positive tissue culture supernatant) and 4 negative controls from FMDV negative tissue
culture supernatants. All samples were run three times and a mean calculated from these
values. The threshold value for each run was optimised using the 4 replicates of the
positive controls. In each case, the threshold value was taken during the linear phase of
amplification when the standard deviation of the mean from the 4 positive control
replicates was lowest.
2.11 Interferon-gamma enzyme immunoassay
Interferon-gamma (IFN-y) levels in plasma from experimental animals were assayed
using a commercially available monoclonal antibody-based sandwich enzyme
immunoassay (BOVIGAM™; CSL Veterinary, Australia). The 96% homology between
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ovine and bovine IFN-y allows the immunoassay to be used to detect ovine IFN-y
(Rothel et al., 1990). Samples were assayed as the manufacturers protocol. Briefly, 50 pi
of test sample was added to 50 pi of diluent in wells ofmicroplates coated with antibody
to bovine IFN-y. Plates were mixed for 1 min on a plate shaker and incubated at room
temperature for 60 min. Following incubation, all wells were washed 6 times with wash
buffer before addition of 100 pi of horseradish peroxidase labeled anti-bovine IFN-y
conjugate. Plates were incubated at room temperature for 60 min, washed as before and
100 pi of enzyme substrate buffer (containing H2O2) containing chromogen
(tetramethylbenzidine (TMB) in dimethyl-sulphoxide) added. The reaction was
terminated after 30 min by the addition of 50 pi 0.5M H2SO4 and read at 450nm using a
Dynex MRX platereader. A cut-off for positive samples was determined as the mean of
the three negative control wells plus two standard deviations of the mean. To assess the
repeatability of the assay, samples were tested in duplicate (figure 2.1). The results show
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Figure 2.1. Repeatability of the IFN-y enzyme immunoassay. Duplicate samples
were tested as section 2.11. Pearson's linear correlation: R2= 0.828, N=32, p<0.001.
2.12 Definitions of infection status
For all experimental animals the final infection class has been defined as follows.
Clinical infections are defined as those where vesicular lesions occurred. Inapparent
infections are defined as those where viraemia occurred but without the occurrence of
clinical signs. Subclinical infections are defined as those where seroconversion was the
sole indicator of FMDV infection.
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CHAPTER 3: THE EPIZOOTIC OF FOOT-AND-MOUTH
DISEASE IN GREECE DURING 1994
3.1 The epizootic
Between August and October of 1994 an epizootic of foot-and-mouth disease (FMD)
occurred in Greece. The last outbreak of FMD had occurred 10 years previously in
the "buffer" zone along the Evros river where Greece borders Turkey (Tsaglas,
1995). The implementation of a non-vaccination policy by the European Union in
1991 created an entirely susceptible population of small ruminants in Greece. A total
of 96 outbreaks of clinical FMD occurred in 6 separate prefectures although a
retrospective serological survey revealed that foot-and-mouth disease virus (FMDV)
infection had spread to 4 other areas (figure 3.1).
Despite the predominant numbers of small ruminants on affected holdings compared
to other FMD susceptible species (13 sheep/goats to every 1 cattle/pig), the virus
showed no predilection for small ruminants (Mackay et al., 1995). The morbidity and
mortality for cattle and pigs combined were both higher than for sheep and goats
combined (49.5% of cattle and pigs infected compared to 18.0% of small ruminants
within clinically infected prefectures; 4.5% mortality for infected cattle and pigs
compared to 0.6% for infected sheep and goats; Mackay et al., 1995). This evidence
suggests that the virus was not sheep-adapted.
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Control measures adopted during the epizootic were the stamping out of seropositive
animals and the slaughter of in-contact livestock within affected holdings. The
implementation of control measures was limited by the efficiency of the clinical
surveillance programme which was in many cases inadequate (P Kitching, Pers.
comm.) and hindered by the mild clinical signs of FMD in small ruminants (Geering,
1967). Post-epizootic serology indicated that infection had spread more intensively
than was originally thought.
3.2 Source and spread
The primary route of infection was infected sheep moved from the island of Lesbos
to the mainland. Illegal trade of animals had been occurring on Lesbos between
Turkish farmers and Greek farmers. The island is situated close (4 km) to the Turkish
mainland and due to the lower prices of Turkish sheep (Tsaglas, 1995) it is suspected
that FMD infected sheep were moved onto Lesbos sometime before the beginning of
May (Davies, 1995). Greek farmers receive a headage count payment from the EU at
the end ofMay based on the size of their flock, and the cheap prices of Turkish sheep
encouraged farmers on Lesbos to augment the size of their flocks by illegally
importing sheep from Turkey (Davies, 1995). Nucleotide sequencing of the major
capsid gene (VP1) showed that the virus circulating in Greece was closely related to
that circulating in Turkey between 1991 and 1994 (Knowles & Samuel, 1995). FMD
was only confirmed on Lesbos following confirmation of FMD in Xanthi. The
conditions on Lesbos seem to have enabled FMDV to successfully maintain itself for
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a period of possibly 2 months before recognition by the veterinary authorities. This is
the time period between when it is assumed sheep were being smuggled onto Lesbos
(to increase the headage count) and confirmation of the first case of FMD. The
number of outbreaks of clinical FMD on Lesbos will have been under-reported but
serosurveillance data do indicate an increased prevalence of FMDV infection on































































3.3 Analysis of clinical outbreaks
The course of clinical FMD during the epizootic is shown graphically in figure 3.2.
For the purpose of this analysis the course of the epizootic has been divided into
three distinct phases.
1. The introduction of infected sheep onto the island of Lesbos. Four outbreaks
of FMD on Lesbos were due to illegal importation of sheep from Turkey
(Mackay et al., 1995). Five outbreaks occurred in Evros due to similar illegal
animal movements but no secondary outbreaks occurred. In all probability the
number of clinical outbreaks occurring on Lesbos will have been much higher.
Outbreaks of FMD will have occurred during the 2 months following movement
of infected sheep from Turkey and confirmation of FMD.
2. Movement of infected animals from Lesbos to Rodopi and Xanthi.
Epidemiological investigations discovered that 14 consignments of infected
sheep had moved from Lesbos to various areas of northern Greece (Davies,
1995). One consignment is known to have reached each of Attiki, Kastoria,
Kilkis and Kavala. The remaining 10 consignments arrived at either Rodopi or
Xanthi. These 10 foci of infection resulted in 35 secondary outbreaks (Mackay et
al., 1995).
3. Spread of FMD on mainland Greece. The 35 outbreaks due to direct contact
with infected animals from Lesbos caused a further 29 outbreaks of FMD within
Rodopi and Xanthi. The remaining 4 outbreaks of clinical FMD occurred in
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regions not neighbouring infected prefectures. The outbreak in Larissa is known
to have occurred following movement of infected sheep from Rodopi (Tsaglas,
1995) but the source of virus for the 1 outbreak in Serres and 2 outbreaks in
Halkidiki is unknown. The Greek Veterinary Services reported that 4 outbreaks
of FMD were due to transport of infected animals on the mainland (Mackay et
al., 1995). All satellite outbreaks occurred after the outbreaks in Rodopi and
Xanthi (disease outbreaks reported to the Office International des Epizooties in
July, August, September and October 1994). For the purpose of this analysis, all
three foci of outlying outbreaks (Serres, Halkidiki and Larissa) are assumed to be
part of the same phase and caused by contact with the 35 primary outbreaks in
Rodopi and Xanthi. Although the outbreaks of FMD in Kilkis and Kavala were
termed subclinical by the reporting authorities, it is possible that mild clinical
disease occurred undetected within these areas. If this was the case, spread of
FMD from these areas to Serres and Halkidiki can not be ruled out.
The numbers of primary and secondary outbreaks for the three phases are shown in
figure 3.3. Reproduction ratios (R) for the three phases above have been calculated as
the ratio of secondary outbreaks to primary outbreaks (Haydon et al., 1997) and are
shown graphically in figure 3.4. The threshold value of 1 for R (Diekmann et al.,
1990) has been added to figure 3.4. If R falls below this threshold each primary case
fails to replace itself and the epidemic will fade. For the purpose of this study the
epidemiological unit is considered a livestock holding rather then an individual
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animal as is used in standard applications of theory. Reproduction ratios are upper
estimates.
Figure 3.4 shows that R fell below the threshold level required for successful
invasion and maintenance of infection within a susceptible population, shortly after
reaching the mainland. The morbidity rate for sheep on affected prefectures was only
18% (Mackay et al., 1995). This suggests that the number of remaining susceptible
hosts, due to the infection process, was unlikely to be solely responsible for any
diminution in R seen during the epizootic, as the ratio of susceptible hosts to


























































































































Figure 3.3. Primary and secondary outbreaks of foot-and-mouth disease in
Greece during 1994. Blue bars show primary outbreaks, red bars secondary
outbreaks. T-L = following introduction of FMDV to Lesbos from Turkey. L-R/X =
following movement of infected sheep to mainland Greece (Rodopi and Xanthi).










Figure 3.4. Reproduction ratios (R) for the epizootic of foot-and-mouth
disease in Greece during 1994. R values were calculated as the ratio of
secondary outbreaks to primary outbreaks using the data shown in figure 3.3.
The broken line shows the threshold value of 1. T-L = following introduction of
FMDV to Lesbos from Turkey, L-R/X = following movement infected sheep to
mainland Greece (Rodopi and Xanthi). Mainland = spread of FMDV on
mainland Greece from primary outbreaks in Rodopi and Xanthi.
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3.4 Serological survey
The epidemiological pattern within affected prefectures was in some cases extremely
complicated due to the density of animal holdings. This made successful tracking of
infected animal movements difficult for the Greek authorities (Mackay et al., 1995).
It was also suspected that undetected FMD may have spread from infected
prefectures, particularly where a large number of outbreaks had occured. The nature
of FMD in sheep is mild and in many cases asymptomatic (Geering, 1967) and the
possibility remained that, throughout the course of the epizootic, outbreaks of FMD
had been drastically under reported. A serological survey was performed in 10 km
areas around sites of either (a) clinical disease, (b) where consignments of infected
sheep had arrived and (c) in a number of "random" holdings within each prefecture.
Floldings classified as "random" were selected after the establishment of
epidemiological links with known outbreaks of disease and it has been suggested that
the holdings should have been classified as in-contact but insufficient data were
available for all holdings to allow this classification (Mackay et al., 1995).
Random sampling of 14 small ruminants was performed on each holding to provide a
95% confidence of detecting infection given 20% prevalence of seropositive animals
on each holding (Mackay et al., 1995). Animals sampled were individually identified
and sera tested for antibodies against FMDV at one of five laboratories: the World
Reference Taboratory for FMD, Pirbright, UK; the Institute for Animal Science and
Health, Lelystad, Netherlands; the Danish Veterinary Institute for Virus Research,
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Lindholm, Denmark; the Bundesforshungsanstalt fur Viruskrankheiten der Tiere,
Tubingen, Germany and the FMD Institute, Athens, Greece.
Samples were examined by liquid-phase blocking ELISA (Hambline/ al., 1986) with
an elevated threshold level for positive samples due to the large numbers of samples
that appeared borderline positives (Mackay et al., 1995). If 1 or more samples from a
holding tested positive the holding was revisited and a further 28 samples collected.
This provided a 95% confidence of detecting infection given only 10% prevalence of
seropositive animals on each holding (Canon & Roe, 1982).
3.4.1 Results
Table 3.1 shows the results of serological testing by prefecture. Data from table 3.1
are shown graphically in figure 3.5 as proportions of positive samples with 95%
confidence intervals.
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Prefecture Clinical Sera Number % positive
disease tested positive (prefectural
attack rate)
Lesbos + 964 150 15.6
Xanthi + 10928 730 6.7
Evros + 3033 151 5.0
Serres + 748 36 4.8
Rodopi + 8567 350 4.1
Halkidiki + 831 17 2.0
Kastoria - 640 50 7.8
Kilkis - 2283 114 5.0
Kavala - 3797 183 4.8
Attiki - 494 2 0.4
Table 3.1. Results of the serological survey performed following
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Figure 3.5. Results of the serological survey performed following the
epizootic of foot-and-mouth disease in Greece during 1994. Binomial error bars
show 95% confidence limits of the proportion positive. Red markers indicate
prefectures were clinical FMD was reported and are shown in chronological order of
occurrence, starting with Lesbos. Blue markers show prefectures where clinical
FMD was not detected.
3.5 Population effects on transmission
To assess the correlation between host population demographics and prefectural
attack rate, livestock numbers were obtained from a census of Greece taken in 1996
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(supplied by Greek Veterinary Services). Although farming practices are known to be
similar throughout Greece (P Kitching, Pers. comm.) there is considerable variation
in the total number of livestock, average flock size and the density of livestock
within prefectures (table 3.2). Sheep make up the vast majority of the FMDV
susceptible livestock in all prefectures. For calculation of livestock densities, data
from the 1996 survey of livestock numbers has been combined with land area data
for prefectures of Greece (supplied by IGD Group, Athens, Greece).
Prefecture Number of livestock Number Average Flock
of flocks flock size density
thousands % sheep (per sq km)
Evros 243 94 3278 176 0.31
Rodopi 298 94 5815 142 0.78
Xanthi 160 88 3533 105 0.74
Lesbos 320 98 12052 28 5.27
Attiki 183 95 N/A N/A N/A
Kavala 179 94 1424 284 0.28
Halkidiki 180 98 1110 212 0.22
Kilkis 218 86 3587 206 0.35
Serres 328 88 4890 165 0.44
Kastoria 77 94 77 126 0.33
Table 3.2. Livestock data for prefectures of Greece in 1996.
3.5.1 Population size
Figure 3.6 shows the relationship between population size (total number of livestock)
and prefectural attack rate (percentage seroconversion). Table 3.2 shows that sheep
make up the vast majority of FMDV susceptible livestock within each prefecture.
Non-parametric correlation analysis shows no significant correlation between
population size and prefectural attack rate (Spearman's rank correlation coefficient
rs=-0.012; N=10; p=0.973).
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3.5.2 Number of sheep flocks
Figure 3.7 shows the relationship between the number of sheep flocks and prefectural
attack rate (percentage seroconversion). Non-parametric correlation analysis shows
no significant correlation between the number of sheep flocks and prefectural attack
rate (Spearman's rank correlation coefficient rs=0.101; N=9; p=0.769). The data
point for Lesbos is an extreme outlier and so the results of analysis are difficult to
interpret.
3.5.3 Flock size
Figure 3.8 shows the relationship between average size of flock and prefectural
attack rate (percentage seroconversion). Non-parametric analysis of the data shows a
significant negative correlation between flock size and prefectural attack rate
(Spearman's rank correlation coefficient rs=0.698; N=9; p=0.037) but when the data
point for Lesbos is excluded gives no significant negative correlation (Spearman's
rank correlation coefficient rs=-0.563, N=8, p=0.143).
3.5.4 Host density
Figure 3.9 shows the relationship between the density of sheep flocks and prefectural
attack rate (percentage seroconversion). Non-parametric analysis of the data shows
no significant correlation (Spearman's rank correlation coefficient rs=0.437; N=9;
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p=0.240). The density of sheep flocks and cattle herds combined, cattle herds only,
total number of sheep, total number of cattle and the density of all livestock
correlates less with prefectural attack rate than the density of sheep flocks. The data
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Figure 3.6. Relationship between population size (total FMDV
susceptible livestock) and the prefectural attack rate of FMDV for the
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Figure 3.7. Relationship between the number of sheep flocks and the
prefectural attack rate of FMDV for the epizootic of Greece during 1994.













1 2.0 ! ♦
< 0.0
0 50 100 150 200 250 300
Average size of flock
Figure 3.8. Relationship between the average size of flock and the
prefectural attack rate of FMDV for the epizootic in Greece during 1994.
Spearman's rank correlation coefficient rs=-0.698; N=9; p=0.037 (all points),
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Figure 3.9. Relationship between the density of sheep and the prefectural
attack rate of FMDV for the epizootic in Greece during 1994. Spearman's
rank correlation coefficient ^=0.437, N=9, p=0.240.
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3.6 Discussion
Of the characteristics of this epidemic, the significantly greater attack rate of FMDV
on Lesbos compared to the rest of the mainland is perhaps the most intriguing. The
conditions on Lesbos greatly favoured the transmission of FMDV and provided an
ideal environment for maintenance. The density of sheep flocks on Lesbos was a
minimum of 6.8 times higher than in any of the other regions of Greece affected by
the epizootic and the total number of sheep flocks a minimum of 2.3 times higher.
Both the density of susceptible sheep and the numbers of flocks have assisted
transmission of this isolate within and between sheep flocks. The density of sheep in
different areas provides an indication of the likelihood of an infected flock making a
successful contact (contact in which transmission of FMDV occurs) with a naive
flock. Not only was this likelihood considerably higher on Lesbos, but the large
number of flocks ensured there was a greater pool of susceptible flocks of sheep. The
size of the recipient flock may not influence the degree to which FMD disseminates
through the susceptible population. Above a minimum threshold, the low morbidity
of this virus for sheep means that saturation of a flock with infected sheep is unlikely
to occur. Although average flock size and prefectural attack rate are significantly
negatively correlated, this only applies when the data point for Lesbos is included.
Removal of this outlier removes any significant correlation. The critical factor for
transmission may not be the size of the flock but the number of individual distinct
flocks. Minimum flock size would only influence transmission if the flock were
small enough for a certain proportion of the population to become infected quickly
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and thus reduce the size of the in-contact susceptible population so that the flock was
partially saturated with infected individuals, and the density of susceptible hosts had
fallen below the optimum.
Once FMDV reached mainland Greece there was a reduction in flock-to-flock
transmission (below the threshold level necessary for successful maintenance) and
attack rate. R has been estimated for distinct phases of the epizootic and all outbreaks
not known to have been caused as a result of direct contact with infected shipments
of sheep, have been classified as secondary outbreaks. In reality a number of these
will have been tertiary or greater outbreaks. Also, the 35 outbreaks that occurred due
to contact with the 29 outbreaks caused by contact with infected sheep introduced to
Xanthi/Rodopi, could have been classified as tertiary outbreaks within that phase.
This distinction does not effect the decline in R below the threshold of 1. Some of
the variation in R can be attributed to differences in the parameters that contribute
towards R (Haydon et ai, 1997). These include environmental factors that are know
to contribute to transmission of FMDV such as temperature and atmospheric relative
humidity (Sorenson et al., 2000) and demograhical parameters such as livestock
density and flock size described above. For those prefectures where clinical FMD
occurred and where the dates that outbreaks began are known (Xanthi, Rodopi and
Halkidiki), there was a gradual reduction in attack rate upon reaching the mainland.
The five outbreaks in Evros are known to have occurred through direct contact with
infected sheep from Turkish Thrace and as such make up a separate arm of the
epidemic. The four outbreaks where clinical disease was not reported (Attiki, Kavala,
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Kastoria and Kilkis) are all known to have received infected sheep directly from
Lesbos. The dates of these shipments are unknown so it is difficult to interpret the
serological data in terms of the rest of the epizootic. It is also difficult to assess
changes in the clinical severity of FMD throughout the epizootic, as clinical
surveillance was inadequate.
With successive generations of infection, reduction in both the number of new
outbreaks and the attack rate ofFMDV within infected prefectures led to an epizootic
that displayed "self-limiting" properties. Such an outbreak may be defined as an
epidemic during which, without external intervention, the pathogen is unable to
maintain the force of infection necessary for passage through successive fully
susceptible populations. The outbreak control strategies applied during this epizootic
attempted to reduce the spread of virus by restricting transmission opportunities and
reducing the infectious population. Stamping-out of FMD during this epidemic
consisted of removing seropositive and in-contact animals. Removal of seropositive
animals would not have influenced attack rates as these animals are no longer
infectious and may even have increased the contact rate between infectious and
susceptible sheep (by increasing the probability that an infectious individual makes
contact with a susceptible sheep rather than a recovered one). The slaughter of in-
contact animals may have restricted intra-flock transmission through the removal of
incubating cases and by reducing the local susceptible population, and subsequently
also reducing the contact rate between infectious and susceptible animals. EU
missions to Greece during the epidemic found that the EEC council directives for
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implementation of control measures were not being correctly enforced (P Kitching,
Pers. comm.). This evidence suggests that the influence of control measures in
restricting spread was minimal. Analysis of FMD epidemics has clearly
demonstrated that the most effective control measure is the rapid slaughter of all
animals within an affected holding (Haydon et al., 1997, Howard & Donnelly, 2000).
Failure to perform this action can increase the size of the epidemic dramatically. In
this instance, the lack of rigorously enforced slaughter policies does not seem to have
increased the size of the epizootic, suggesting that the characteristics of this epidemic
were not classical.
The contribution of virological factors to the inability of this strain of FMDV to
successfully infect successive generations is unclear. This analysis shows that the
demographics of susceptible populations in part influence transmission of this strain
between sheep flocks. Conditions on Lesbos (high density, large number of flocks)
ensured that levels of virus were maintained and perhaps amplified to levels capable
of infecting a number of prefectures on the mainland. Once FMDV reached the
mainland, conditions were unfavourable for maintenance and there followed a
gradual decline in the degree of transmission within an affected flock. There is
considerable variation in the attack rates of FMDV on mainland Greece and the
reasons for this variation are not apparent from epidemiological analysis alone. In an
attempt to understand the relationship between pathogen and host a number of
experiments have been performed to assess virological influence on transmission
between sheep. Dose-dependent infection with FMDV may have influenced the
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transmissibility of this isolate on the mainland. The infectiousness of a shipment of
sheep may vary drastically and the subsequent success of FMDV in invading the
susceptible population will depend on the force of infection provided from infectious
animals at the time contact with the new susceptible population begins. The six
prefectures that received shipments of infected sheep from Lesbos had varying attack
rates. These attack rates varied from 7.8% (Kastoria) to 0.4% (Kilkis). A virus with
an inability to successfully maintain itself within groups of susceptible hosts would
result in a force of infection that, beyond a certain point, would continuously decline.
Effective contact with susceptibles beyond this point would be less and less probable
with time. On an infected flock to susceptible flock basis this would relate to a
gradual reduction in attack rate. Unfortunately, we are unaware of the chronological
order at which shipments arrived on the mainland from Lesbos. The lack of virus
isolates from every stage of this epizootic also restricts the use of molecular
epidemiology to investigate this problem. Transmission from sheep inoculated with
varying doses of this isolate of FMDY is assessed in chapter 4. The inability of an
exposed flock to amplify or maintain the per flock challenge dose has been
investigated in chapter 5. The characteristics of this epizootic may have been as a
result of the introduction of a non-sheep-adapted virus into a large sheep population.
Only the ideal conditions on Lesbos enabled this virus to maintain itself for such a
relatively long period of time.
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CHAPTER 4: DOSE DEPENDENT TRANSMISSION OF
FOOT-AND-MOUTH DISEASE VIRUS IN SHEEP
4.0 Introduction
The minimum dose required to infect sheep with foot-and-mouth disease virus
(FMDV) has previously been reported as 10 TCID50 from experiments where
sheep were individually exposed to aerosols from infected pigs (Gibson &
Donaldson, 1986). The experiments described in this chapter have not been
performed in an attempt to refine or supplement this value but to assess the effect
of dose on the characteristics of infection for inoculated and in-contact sheep and
to assess the effects of dose on the infectiousness of inoculated sheep. During the
outbreak of foot-and-mouth disease (FMD) in Greece, from which the virus
isolate used in these experiments was taken, there was a reduction in transmission
after passage through a number of sheep flocks (Mackay et al., 1995). A
continuous decline in the infectious dose may explain the reduction in
transmission seen during this epidemic.
4.1 Experimental design
• j 3
Five identical experiments were performed using a range of inoculum dose (10 ,
103 5, 104, 105 and 106 fifty percent tissue culture infective dose (TCID5o/ml),
herein referred to as experiments 1-5 respectively. Sheep were inoculated
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intranasally with the required dose in 2 ml of M25 phosphate buffer using a 2-inch
length of sterile rubber tubing. For each experiment a total of 15 sheep were used;
five animals were inoculated (Group 1; Gl) with the required dose and 24 hrs later
10 in-contact animals were introduced (Group 2; G2). All experiments were
performed in identical boxes within high security isolation units. Monitoring was
continued until all infected animals were deemed no longer infectious (7 days after
the cessation of viraemia) and sufficient time had been allowed for incubating
susceptibles (10 days).
4.1.1 Inoculum preparation
FMDV type O Greece 23/94 (originally isolated from ovine epithelium using
primary calf thyroid cells; BTY) was passed again in BTY cells before titration as
described in section 2.3. This stock virus was aliquoted and stored at -70°C. The
required dilutions for inoculation were calculated and virus stock diluted
immediately prior to administration with M25 phosphate buffer. All inoculum
solutions were re-titrated immediately upon return to the laboratory to confirm the
given dose.
4.1.2 Sampling protocol and methods
On each day of the experiment, 5 ml of peripheral blood and 5 ml of heparinised
peripheral blood were taken for serology and virus isolation respectively. Virus
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isolation was performed as section 2.2. Plasma samples positive by virus isolation
were titrated in BTY cells as described in section 2.2. Total serum antibody
responses were measured as section 2.5. Throat swabs were taken daily using a
cotton tipped polypropylene swab (Technical service consultants Ltd.). Tips were
cut off immediately into 1 ml of TRIzol (Gibco, BRL) for RNA extraction and
subsequent reverse transcription nested polymerase chain reaction (RT-nPCR; as
described in section 2.9). All sheep were examined daily for clinical signs of FMD
in the mouth and on all four feet. Rectal temperatures were recorded daily.
Oesophageal-pharyngeal fluid (OPF) was taken from every animal on the final day
of the experiment and processed as section 2.6. Interferon-gamma (IFN-y) levels
in plasma of G1 sheep were measured using the BOVIGAM™ enzyme
immunoassay (CSL Veterinary, Australia) as described in section 2.11.
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4.2 Results
An overview of each experiment is shown in figures 4.1-4.4. Experiment 1 is not
included as no positive samples were found.
4.2.1 Experiment 1
Inoculation of sheep with the lowest dose (103 TCID5o) was insufficient to cause
clinical or subclinical infection. There was no evidence of any form of
transmission between G1 and G2. No live virus was isolated from OPF samples
taken 10 days post-inoculation.
4.2.2 Experiment 2
Inoculation of sheep with 103 5 TCID5o was insufficient to cause clinical infection.
A short term, low-level serum antibody response was detectable in one member of
both G1 and G2. No live virus was isolated from OPF samples taken 18 days post-
inoculation.
4.2.3 Experiment 3
All G1 sheep inoculated with 104 TCID50 developed viraemia and 8 of G2. One
member of G1 did not develop vesicular lesions. The remaining two members of
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G2 developed subclinical FMD. Virus was recovered from all OPF samples taken
(22 days post inoculation) from G1 sheep and from 4 samples taken from G2
animals.
4.2.4 Experiment 4
All G1 sheep inoculated with 105 TCID5o developed viraemia and 6 of G2. One
member of G1 did not develop vesicular lesions. Of the 4 remaining G2 sheep, 1
developed subclinical infection. Virus was recovered from 3 OPF samples taken
(24 days post inoculation) from G1 sheep and from 3 samples taken from G2. The
time that the last two G2 sheep developed viraemia was 4 and 6 days after the last
viraemic day of Gl. This suggests that transmission to these two sheep was from
contact with infectious members ofG2 and not from Gl.
4.2.5 Experiment 5
Inoculation with 106 TCID50 resulted in clinical disease in 4 Gl sheep and
subclinical infection in the fifth. There was no infection in any G2 sheep. Live
virus could not be recovered from OPF samples taken 19 days post-inoculation
from G2 sheep. Virus was recovered from four of the five OPF samples taken
from Gl sheep, including the sample from the animal with subclinical infection.
To test the susceptibility of uninfected G2 sheep, all 10 were challenged 21 days
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post-contact with 105 TCID50 of stock virus by intranasal instillation. All G2 sheep
developed viraemia (detectable by virus isolation) by 3 days post-challenge.
4.2.6 Transmission
The final outcome for each experiment is shown in table 4.1. The proportion of










Subclinical Inapparent Clinical Total
G1 G2 G1 G2 G1 G2 G1 G2 G1 G2 G1 G2
1 103° 0 0 0 0 0 0 0 0 0 0 0.00 0.00
2 1035 1 1 0 0 0 0 1 1 0 0 0.02 0.06
3 104° 0 2 1 0 4 8 5 10 4 4 0.42 0.36
4 105° 0 1 1 1 4 53 5 7 4 4 0.53 0.11
5 0 <J> 0 1 0 0 0 4 0 5 0 4 0 0.09 0.02
Table 4.1. Final infection status of sheep and indicators of transmission from dose-
dependent transmission experiments. Vrobang results show numbers of samples
positive by virus isolation. 2Throat swab results show the mean proportion of positive swabs
(by RT-nPCR) per sheep per day. infection of the last two cases of clinical FMD in G2 from
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Figure 4.5. Infection status of sheep following inoculation and
contact from dose-dependent transmission experiments.




For each experiment, the mean number of positive throat swabs (determined by
RT-nPCR) per sheep per day was calculated (table 4.1). For each group, day zero
samples were not included in calculation of the mean as these were negative
controls. Values were calculated irrespective of infection status within the same
time period for every experiment. The period used was the longest possible i.e. the
duration of the shortest experiment, which corresponded to the 18 days of
experiment 2. From this, means were calculated from 18 samples for G1 sheep
and 17 samples for G2 sheep. Throat swab results are shown graphically in figure
4.6. To assess whether the occurrence of positive throat swabs was clustered
(corresponding with the infectious period) runs test was performed on throat swab
data to test the randomness of the occurrence of positive results (table 4.2). The
results of a runs test signify whether events (in this case the occurrence of a
positive throat swab) occur in a random order or appear as a function of a previous
event (in this case a proceeding positive throat swab). Significant values (p<0.01)
indicate that positive throat swabs occurred in a non-random fashion. Figure 4.7
shows the number of positive throat swabs per day taken throughout the course of
the experiments. Figure 4.8 shows the number of positive throat swabs and the
frequency of new infections for experiments 3 and 4 (104 and 103 TCID50).
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Figure 4.6. Mean proportion of positive throat swabs (by RT-
nPCR) taken from sheep during dose-dependent transmission




Group Sheep No. of runs Z P
1 TT9 8 -0.684 0.494
TT10 5 -1.928 0.054
TT11 10 0.000 1.000
TT12 5 -2.161 0.031
TT13 8 -0.684 0.494
2 TT14 7 -0.698 0.485
TT17 3 -2.788 0.005
TT18 9 0.000 1.000
TT19 7 -0.698 0.485
TT20 6 -1.494 0.135
TT21 4 -2.499 0.012
TT22 7 -0.698 0.485
TT23 4 -2.454 0.014
1 TW41 10 0.000 1.000
TW42 7 -0.826 0.409
TW43 13 1.510 0.131
TW44 8 -0.541 0.588
TW45 5 -1.674 0.094
2 TW46 6 0.000 1.000
TW48 1 -
a
TW51 3 0.000 1.000
TW52 1 - -
TW54 5 -0.400 0.689
TW55 7 -0.342 0.733
1 TZ91 3 0.000 1.000
TZ92 5 0.000 1.000
TZ93 3 -2.692 0.007
TZ94 9 0.924 0.355
Table 4.2. Runs test for the occurrence of positive throat swabs taken
from clinically infected sheep during dose-dependent transmission
experiments. aWhen only one run occurred the runs Test could not be
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Figure 4.7. Numbers of positive throat swabs per day taken from sheep
during dose-dependent transmission experiments. Throat swabs were
tested by RT-nPCR for the presence of viral RNA. Values in the legend
indicate dose (log10 TCID50).
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Figure 4.8. Numbers of positive throat swabs and frequency of contact
infections for dose-dependent transmission experiments 3 and 4. Numbers
of positive throat swabs are from G2 sheep only and are shown by the blue line.
Red bars show the number of new G2 viraemias occurring on each day of the
experiment post inoculation of G1. The figures show that the levels of virus
circulating in the box following inoculation with 104 TCID50 were higher than with
inoculation of 105 TCID50.
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4.2.7 Dose-dependent responses to infection
4.2.7.1 Clinical foot-and-mouth disease
Mean incubation periods for G1 sheep were calculated using the time between
inoculation and the occurrence of a detectable viraemia as individual values (table
4.3). Table 4.4 shows the mean number of lesions per clinically infected sheep and
the mean number of sites affected by FMD for clinically infected sheep. A site
was classified as affected by FMD if vesicular lesions were found. Lameness was
not considered a definitive sign of FMD for in a number of cases lameness was
caused by factors other than FMDV infection, such as foot rot. In determining the
number of sites affected, 5 possible sites were considered: each foot and the
mouth. One-way analysis of variance (ANOVA) using the Tukey method for
multiple comparisons (where applicable) was performed for incubation period
data and for both measures of clinical FMD. Data showed no significant
departures from normality (p>0.05) using the Kolmogorov-Smirnov test and were






3 104 3.4 (5.1-1.7)a
4 105 1.2 (1 8-0.6)b
5 10s 1.5 (2.4-0.6)b
Table 4.3. Incubation periods for G1 viraemic sheep
from dose-dependent transmission experiments.
Numbers in brackets show 95% confidence limits of the
mean. ANOVA (with multiple comparisons using the
Tukey method) showed significant differences between
values marked a and b (p<0.05).
Expt. Dose
(TCIDso)
Mean number of lesions per
clinically infected sheep
Mean number of sites affected1
G1 G2 G1 G2
3 104 3.8 (6.4-1.2) 4.3 (5.2-3.3) 2.4 (3.7-1.1) 2.4 (3.0-1.7)
4 105 1.8 (3.8-0.2) 4.0 (5.9-2.1) 1.6 (2.8-0.4) 3.0 (4.2-1.8)
5 106 2.5 (4.4-0.6) - 1.8 (2.7-0.8) -
Table 4.4. Severity of clinical disease for sheep from dose-dependent
transmission experiments. Numbers in brackets show 95% confidence limits of the
mean. 1A total of 5 sites were included in calculation of the number of sites affected:
four feet and the mouth. ANOVA (with multiple comparisons using the Tukey method
for G1) showed no significant differences between any groups (p>0.05).
4.2.7.2 Viraemia
Characteristics of viraemia are shown in tables 4.5 and 4.6. The time interval
between the onset of viraemia and the start of seroconversion (Ty-s) has been
calculated as a possible indicator of the duration of the infectious period. Figure
4.9 shows the relationship between the peak viral titre and the total viral load.
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Parametric correlation analysis shows that 96% of the variance in the sum of the
viral load is due to the peak viral load. Mean peak viral loads of infected animals
are shown graphically in figure 4.10. ANOVA using the Tukey method for
multiple comparisons (where applicable) was performed on all data for
characteristics of viraemia. All data showed no significant departures from
normality (p>0.05) using the Kolmogorov-Smirnov test and were consistent with
homogeneity of variance using the Levene test (p>0.05). Figure 4.11 shows the
relationship between peak viraemia and clinical signs. Clinical signs data showed
no significant departure from normality using the Kolmogorov-Smirnov test
(p>0.05) and were consistent with homogeneity of variance using the Levene
statistic (p>0.05). Parametric analysis shows that 26% of the variance in the
number of lesions was due to variance in the peak viral load. Analysis of
covariance showed no significant difference in slopes for G1 and G2 (F=1.7;
df=l,2; p>0.05).
Expt Dose Mean length TV-s
(TCIDso)
G1 G2 G1 G2
3 104 3.2 (3.6-2.8)a 3.1 (3.7-2.6) 3.0 (3.8-2.2)a 3.6 (4.2-2.9)
4 105 2.6 (3.1-2.1) 2.8 (3.5-2.2) 4.0 (4.8-3.2)a 3.3 (4.0-2.6)
5 10® 2.0 (3.6-1,4)h - 1 8 (2.2-1.3)b -
Table 4.5. Duration of viraemia and relationship with seroconversion for
infected sheep from dose-dependent transmission experiments. 1Mean time in
days between the onset of viraemia and seroconversion (titres>1/45). ANOVA (with
multiple comparisons using the Tukey method for G1) showed significant differences
(p<0.05) between means marked a and b. Numbers in brackets show 95% confidence
limits of the mean.
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Expt. Dose Log-io mean peak titre Mean Log10 total viral load1
(TCIDso)
G1 G2 G1 G2
3 1 04 5.3 (6.4-4.1)3 5.0 (5.7-4.3)a 5.2 (6.3-4.2)a 4.8 (5.4-4.2)a
4 1 05 3.8 (5 1-2.5) 2.6 (3.9-1.2)b 3.7(5.2-2.2) 2.6 (4.0-1,2)b
5 106 3.0 (5.1-1.0)" - 2.9 (5 0-0.6)b
Table 4.6. Characteristics of viraemia for infected sheep from dose-dependent
transmission experiments. 1An estimation of the total viral load was calculated by
summing the area of trapezia under the viraemic curve. Means are arithmetic means
of logarithmic titres. ANOVA (with multiple comparisons using the Tukey method for
G1) showed significant differences (p<0.05) between means marked a and b.
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Figure 4.9. Relationship between total viral load and the peak viraemic titre of
sheep from dose-dependent transmission experiments. Total viral load was
estimated by summing the area of trapezia under the viraemic curve. Data
represents all viraemic sheep from all experiments. Parametric correlation analysis




















Figure 4.10. Mean peak viral loads of viraemic sheep from dose-
dependent transmission experiments. The blue line shows the mean for
inoculated (G1) sheep, the red line for in-contact (G2) sheep. Error bars
show 95% confidence limits of the mean.
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Figure 4.11. Relationship between peak viraemia and severity of
clinical disease for clinically infected sheep from dose-dependent




An analysis of antibody responses is shown in table 4.7. The time interval between
inoculation and the start of seroconversion (Ti_s) has been calculated as an
estimate of the speed of the humoral immune response and is shown in table 4.7.
This interval consists of the number of clear days between inoculation and
seroconversion (titre>l :45). For G2 sheep the exact point of infection is unknown
but infection has been assumed to have taken place 2 days prior to the onset of
viraemia. This is a conservative estimate of the data from Gibson et al. (1986). T]_
s for G2 equals the corresponding value of Tv-s plus 2 days. Mean peak antibody
titres for groups are shown graphically in figure 4.12. ANOVA using the Tukey
method for multiple comparisons (where applicable) was performed on all data for
characteristics of antibody responses. Data showed no significant departures from
normality (p>0.05) using the Kolmogorov-Smirnov test and were consistent with
homogeneity of variance using the Levene test (p>0.05). Figure 4.13 shows the
relationship between antibody responses and peak viraemic titres. Spearman's
rank correlation coefficient (rs) shows no significant association between peak
antibody levels and the level of peak viraemia (rs=0.130, N=28, p=0.505) and Ti_s





G1 G2 G1 G23
2 1035 128 91 5 -
3 104 2896 (3590-2336) 1878 (2328-1515) 5.0 (5.9-4.1)a 5.6 (6.3-4.8)
4 105 1783 (2106-1510)a 1625 (2083-1268) 5.0 (5.9-4.1)3 5.3 (6.2-4.5)
5 106 4096 (6294-2666)b - 3.2 (4.0-2.5)b -
Table 4.7. Antibody responses of clinically infected sheep from dose-dependent
transmission experiments. 1Mean values were calculated by back-transformation of log2
coded individual peak antibody titre 2T|.S shows the mean number of days between
inoculation and the onset of seroconversion (titre>1:45). 3For G2 animals the time of infection
has been assumed to be 2 days prior to the onset of viraemia and the value in the table
adjusted as 2 days greater than the TV-s value in table 4.4. Values in brackets show 95%
confidence limits of the mean. ANOVA (with multiple comparisons using the Tukey method
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Figure 4.12. Mean peak antibody titres for sheep from dose-dependent
transmission experiments. Geometric mean values were calculated by back
transmission of log2 coded individual antibody titres. Error bars show 95%
confidence limits of the mean.
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Figure 4.13. Relationship between antibody responses and peak viraemic
titres for sheep during dose-dependent transmission experiments. T|.s is the
mean number of days between infection and seroconversion. For G2 sheep the
point of infection has been assumed to be 2 days prior to the onset of viraemia.
Antibody titres are log2 coded.
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4.2.7.4 Plasma interferon-gamma levels
Plasma samples from G1 sheep were assayed in duplicate using the BOVIGAM™
interferon-gamma (IFN-y) enzyme immunoassay (as described in section 2.10).
The mean optical density for each sample was normalised against a determined cut
off value (mean of the negative control wells plus two standard deviations). OD
values for G1 sheep are shown in figure 4.14. Table 4.8 and figure 4.15 show the
mean peak IFN-y level, mean duration of the detectable IFN-y response and the
interval between inoculation and peak IFN-y production (T|_|) for G1 sheep.
ANOVA using the Tukey method for multiple comparisons (where applicable)
was performed on all data for characteristics of IFN-y responses. Data showed no
significant departure from normality (p>0.05) using the Kolmogorov-Smirnov test
and were consistent with homogeneity of variance using the Levene test (p>0.05).
Non-parametric correlation analysis (Spearman's rank correlation coefficient, rs)
of the relationship between peak IFN-y production and peak viraemia shows no
significant correlation between the two variables when data are combined for all
three experiments (rs=0.057, N=15, p=0.839) and when each experiment is
analysed separately (104: rs=-0.200, N=5, p=0.747; 105: rs=0.252, N=5, p=0.741;
10b: rs=0.200, N=5, p=0.747). Non-parametric correlation analysis of the
relationship between Tu and peak viraemia shows no significant correlation
between the two variables when data is combined for all three experiments
(rs=0.286, N=14, p=0.322) and when each experiment is analysed separately (104:
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rs=-0.820, N=5, p=0.089; 105: rs=-0.833, N=4, p=0.167; 106: rs=-0.053, N=5,
p=0.933). Figure 4.16 shows the relationship between Tw and T]_s. This figure
demonstrates that there is a significant positive correlation between the occurrence
































Figure 4.14. Plasma IFN-y levels from G1 sheep during dose-
dependent transmission experiments. Levels of IFN-y were
assayed as described in section 2.11 and normalised against a










3 104 0.052 (0.081-0.023) 2.2 (4.2-0.2) 6.2 (8.4-4.0)a
4 105 0.026 (0.050-0.002) 1.6 (3.0-0.2) 3.3 (5.6-0.9)b
5 105 0.074 (0.136-0.012) 2.0 (3.5-0.5) 2.8 (3.8-1.8)b
Table 4.8. Characteristics of IFN-y response for inoculated sheep from dose-
dependent transmission experiments. 1TW is the time interval between inoculation and
peak plasma IFN-y production In calculation of TN the day of peak occurrence was
included in the interval. Values in brackets show 95% confidence limits of the mean
ANOVA (with multiple comparisons using the Tukey method for G1) showed significant
differences (p<0.05) between means marked a and b.


















Figure 4.15. Characteristics of IFN-y production following inoculation
of G1 sheep during dose-dependent transmission experiments. Tw is
the interval in days between inoculation and production of peak IFN-y,
including the day of peak production. Error bars show 95% confidence
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Figure 4.16. Relationship between TM and T|.s for inoculated
(G1) sheep during dose-dependent transmission experiments.
Numbers in the legend indicate dose (log10 TCID50). Tm is the interval
in days between inoculation and the occurrence of peak IFN-y levels.
Ti_s is the interval in days between inoculation and the onset of
seroconversion (titre>1:45). Spearman's rank correlation coefficient
(using combined data) rs=0.60, N=14, p=0.024.
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4.2.8 Principal component analysis
To analyse dose-dependent responses to infection of inoculated (Gl) sheep,
principal component analysis (PCA) of infection variables was performed.
Thirteen sheep were included in the analysis, 5 from experiment 3 and 4 each
from experiments 4 and 5. PCA analysis is unable to tolerate missing data and as a
consequence the non-viraemic sheep (experiment 5) and the sheep that did not
have a detectable plasma IFN-y response (experiment 4) had to be excluded. PCA
was not performed for in-contact (G2) sheep as the number of variables was
inadequate (incubation periods and IFN-y data unavailable). This type of model
studies the correlations among a number of interrelated quantitative variables in an
attempt to resolve the complex relationships between the interaction of various
factors. Linear combinations of the variables are used to characterise the variation
of each dimension in multivariate space and are assessed for their contributions to
the total variance in the data. From this, successive components will explain
smaller amounts of the total variance.
The correlation matrix used in this analysis is shown in table 4.9. Variables used
were those that could contribute to the level of infection within a sheep
irrespective of dose (time interval between inoculation and peak plasma IFN-y
production, incubation period, peak serum antibody levels, peak plasma IFN-y
levels, peak viraemia, and the time interval between the onset of viraemia and
seroconversion). Lesion scores were not included as these occur in response to the
level of infection. Analysis of these variables using PCA with varimax rotation (to
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allow ease of interpretation) resulted in a two-component solution that explained
71.5% of the variance. Eigenvalues for both components and the corresponding
variance explained are shown in table 4.10. Eigenvalues are characteristic roots of
the variance and describe the variance between closely correlated variables.
Components with an eigenvalue of less than 1 were excluded from analysis. Table
4.11 shows the component matrix with coefficients (loadings) that relate the
variables (factors) to the components. Loadings were sorted by size and for
calculation of factor scores for individual animals, values <0.4 were excluded.
Factor scores of individual sheep for each component are shown in figure 4.17. A
summary of the PCA analysis for G1 groups is shown in table 4.12.
Tn T|_v Ab IFN-y Vir Tv-s
Tm 1.000 ~ - - - - -
T,v 0.919 1.000 - - - -
Ab -0.152 0.201 1.000 - - -
IFN-y -0.172 -0 109 0 672 1 000 - -
Vir 0.275 0.279 -0.036 -0.294 1.000 -
Tv-s 0.217 0.193 -0.648 -0.449 0.104 1.000
Table 4.9. Correlation matrix of variables used in the principal
component analysis of data for inoculated sheep from dose-
dependent transmission experiments. Tw = time interval between
inoculation and peak plasma IFN- y levels. I|.v = incubation period. Ab =
peak antibody level. IFN-y = peak plasma IFN-y levels. Vir = peak
viraemic titre. TV-s = time interval between the start of viraemia and the
onset of seroconversion.
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Component Eigenvalue % of Cumulative %
variance of variance
1 2.48 41.3 41.3
2 1.81 30.2 71.5
Table 4.10. Eigenvalues and percentages of variance
explained for components of principal component
analysis of data for inoculated sheep from dose-
dependent transmission experiments. Components with
an eigenvalue <1 were excluded.







Table 4.11. Component matrix for principal components
of data from inoculated animals from dose-dependent
transmission experiments (following varimax rotation).
Values show the loadings that relate variables to the two
components. Tw = time interval between inoculation and
peak plasma IFN-y levels. T|.v = incubation period. Ab = peak
antibody level. IFN-y = peak plasma IFN-y levels. Vir = peak
viraemic titre. TV-s = time interval between the start of







Figure 4.17. Factor scores plot for components of principal component analysis
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Table 4.12. Summary of principal component model for G1 sheep
from dose-dependent transmission experiments. This model summary
has been inferred from table 4.11.
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4.3 Discussion
A summary of the results of these experiments is given in table 4.13.
Response Dose (TCID50)
104 10" 10b
Transmission to in-contact sheep 80% 40-60%1 0%
Numbers of positive throat swabs High High Low
Incubation period* Long8 Short" Short"
Length of viraemia* Long3 Average Short"
Size of viraemia* High3 Low Low"
Seroconversion* Late3 Late3 Early"
IFN-y response* Slow3 Fast"
X1
-•—»(/)CDLi.
Table 4.13. Summary of responses to infection of G1 sheep from dose-dependent
transmission experiments, indicates statistically significant differences in the means
marked a and b (p<0.05). 1Due to the late viraemias of two G2 sheep, the numbers of G2
sheep infected due to contact with G1 could only be 4.
The results of these experiments show there is a complex relationship between the
dose of virus, severity of infection and resulting infectiousness of sheep infected
with this isolate ofFMDV. The lowest dose capable of causing clinical FMD from
this study is 104 TCID50. Previous studies have estimated that 102 TCID50 of a type
O FMDV was the minimum dose that would cause clinical infection in all sheep
exposed directly to aerosols produced by infected pigs (Gibson & Donaldson,
1986). Although the magnitude of the minimum infectious dose differs greatly
between this study and that previously described, there are considerable variations
in the experimental approach used including the strain of virus and method of
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exposure. Field observations suggest that the isolate used for this study was not
adapted for infection of sheep as it had a low morbidity for sheep in the field
(Mackay et al., 1995). This may partially explain the higher minimum infectious
dose. The experiments described here indicate that above the threshold dose
required for infection, clinical FMD occurs for almost all intranasally inoculated
animals. Below the threshold dose there is very limited subclinical infection with
no transmission to in-contact sheep. The optimum dose for transmission from
these experiments was also 104 TCID50. The two doses used below this did not
result in clinical disease for G1 sheep and inoculation with doses higher than this
led to a gradual reduction in transmission from inoculated animals. For
experiment 3 (105 TCID50), although six G2 sheep developed viraemia, the point
at which the last two sheep developed viraemia was 4 and 6 days after the last
viraemic day ofGl. Transmission to these last two sheep probably occurred from
contact with infectious members of G2. Therefore, the number of clinically
infected G2 sheep arising due to transmission from Gl could be as little as four.
Further reduction in the infectiousness with dose was seen when sheep were
inoculated with the highest dose. No transmission occurred from Gl sheep
inoculated with 106 TCID50 to in-contact susceptibles.
The nature of FMD in sheep is such that considerable variation in the spectrum of
clinical disease is seen for infected animals (those with a detectable viraemia).
Within the confines of this study the variation in the number of lesions seen within
individual groups is great. Although the severity of clinical FMD does not vary
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significantly with dose for these experiments, results show that there is a
significant positive correlation between peak viral loads and the severity of
clinical FMD. Parametric correlation analysis indicates that 26% of variance in
clinical signs score can be attributed to variation in the peak viral load. The
sensitivity of these experiments to detect significant variations in the severity of
clinical FMD with dose may be limited by the group size (and consequently
statistical power). Variation in clinical signs with dose was also not seen in a
previous study (Gibson & Donaldson, 1986). Lesions of FMD seem not to be
essential for transmission and in the main occur when sheep are no longer
infectious. Interestingly, for these experiments, when optimum transmission of
FMD occurred (dose of 104 TCID50) 79% (15/19) of vesicular lesions occurred
prior to the onset of seroconversion where as for doses where transmission was
compromised (doses of 105 and 106 TCID50) no lesions occurred before
seroconversion (0/10 and 0/11 respectively). A more reliable indicator of the
severity of FMD infection in relation to infectiousness is perhaps the level of viral
load. The length and peak viral titre of the viraemic period measured here differs
significantly for sheep inoculated with 106 TCID50 compared to sheep inoculated
with 104 TCID50. The level of infection and ability of FMDV to replicate is
reduced with higher dose. The reduced length of the viraemic period for sheep
inoculated with 106 TCID50 was due to seroconversion occurring significantly
earlier for these animals. The onset of seroconversion is known to prevent
excretion of FMDV by neutralisation of virus in circulation and at portals of exit
(Donaldson & Sellers, 1998). Studies show that cessation of excretion of FMDV
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by inoculated sheep corresponds well with the onset of seroconversion (Donaldson
et al., 1970; Sellers et al., 1977). A reduction in the time between inoculation and
seroconversion would shorten the window of opportunity for transmission and
reduce the amount of virus excreted. The results of throat swabs taken from G2
sheep over the course of the experiments suggest that the levels of virus
circulating within the animal box decreased with dose from 104 to 106 TCID50.
The number of positive throat swabs taken from in-contact sheep declines above
the optimum dose for transmission, with the mean proportion positive per in-
contact sheep per day being lower at 106 TCID50 than at 103 5 TCID50. Runs test
analysis of throat swab occurrence implies that swabs taken from inoculated sheep
are not an effective indicator of individual viral excretion.
The dose-dependent effects on transmission and responses of inoculated sheep are
supplemented by dose-dependent responses in the level of infection for in-contact
sheep. Viral loads are significantly higher for G2 sheep exposed to sheep
inoculated with 104 TCID50 than for G2 sheep exposed to sheep inoculated with
105 TCID50. The size of the infecting dose influences not only the degree of
infection of inoculated animals (viral load, infectiousness) but also of those
infected through contact with these animals. Animals infected through contact
with infected sheep exhibit a level of FMDV infection (assessed by viral load)
related to the level of infection seen in the donor animals. The results of this study
suggest that the level of infection of contact infected sheep will always be less that
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that of the donor animals. Similar observations have been found for sheep infected
with other isolates ofFMDV (Burrows, 1968).
The highest dose of virus used in this study may have induced rapid and strong
innate immune responses. Induction of such responses would restrict the spread of
virus from local primary sites of replication (nasal/pharyngeal epithelial tissues
following intranasal inoculation) resulting in the reduced viraemias seen with
sheep inoculated with a high dose of virus. There is a significant reduction in the
incubation period for sheep inoculated with 105 and 106 TCID50 when compared
to animals inoculated with 104 TCID50 suggesting that immune stimulation
beyond local sites would occur earlier than with lower dose. The amount of virus
that escapes local immune surveillance and enters the blood stream induces
antigen dependent differentiation of FMDV specific B-cells leading to the
production of large amounts of serum neutralizing antibody and eventual
clearance of virus from circulation. Early clearance of virus from circulation and
sites responsible for the release of virus into the bloodstream may be mediated by
cytotoxic T-cell activity induced by early innate immune mechanisms. There are
many components of the immune system that may restrict the spread of FMDV
from sites of primary replication. Non-specific inflammatory responses and
associated virucidal components (NK cells, interferons (IFNs) and phagocytic
elements) can block replication of viruses at mucosal surfaces. In the absence of
pre-existing specific antibody (as is the case with susceptible animals), local
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immune responses (IFN-y, slgA and macrophages) at mucosal surfaces rapidly
develop and prevent the spread of virus.
Levels of plasma IFN-y for G1 sheep were measured for these experiments.
Plasma IFN-y is not a measure of local responses that may have reduced the
viraemias seen with higher dose, but they do reflect the level of cell-mediated
reactivity and T cell immunity of the animal induced by the infectious dose (Jones
et al., 1992). Levels of plasma IFN-y reflect the relative stimulation of local
immune mechanisms by antigen. Statistically there is no significant difference
(although the highest mean levels are seen with the highest dose) in the mean peak
IFN-y production of inoculated sheep between experiments. There is a statistically
significant reduction however in the interval between inoculation and peak IFN-y
production for sheep inoculated with 105 and 106 TCID50 compared to those
inoculated with 104 TCID50. This suggests that cell-mediated immune mechanisms
have responded rapidly to the high antigenic dose, stimulated to such a degree that
viral replication is inhibited more so than with lower doses of virus.
There is considerable evidence of a role for IFNs in immunity to FMDV and other
viral infections. Type I IFNs (as well as TNF-a and IL-12) induce the antiviral
state around infected cells shortly after challenge and have recently been
implicated in restricting the local spread of FMDV within experimentally infected
cattle (Brown et al., 2000) and reducing the degree of cytopathic effects and yield
from FMDV infected cells in vitro (Chinsangaram et al., 1999). Type I IFNs
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activate natural killer (NK) cells which in turn produce large amounts of type II
interferon (IFN-y). Type I IFN induction of IFN-y production from NK cells has
been shown to correlate with resistance to encephalomyocarditis virus in mice
(Curiel et al., 1998) and with restriction of spread of Theiler's virus in mice
(Monteyne et al., 1997); both of which are picornaviruses. Dose dependent IFN
responses to FMDV infection do depend on the strain of virus used but increased
doses of virus have been shown to result in increased levels of IFN production in
vitro (Sellers et al., 1968). IFN-y causes upregulation ofMHC class I and class II
antigen presentation, activation of macrophages and differentiation of B-cells and
subsequent IgG2a synthesis. These mechanisms lead to clearance of virus from
sites of infection (through MHC class I presentation and CTL activity) and from
circulation (macrophages) prior to the appearance of serum neutralising antibody.
A reduction in viral load has been shown to correlate well with IFN-y production
for other viruses such as hepatitis C virus (Cramp et al., 1999) and simian
immunodeficiency virus (Khatissian et al., 1996) and may explain the reduced
viral loads seen in this study with high dose. There are many components of the
cell-mediated immune system that contribute to local responses to virus infection.
IFN-y has been measured here as an indicator of the level of T-cell immunity.
IFN-y itselfmay not be directly responsible for cell-mediated restriction, as its role
in host cell defense is largely immunomodulatory. For the purpose of this study,
plasma IFN-y levels serve as a useful marker for the speed and magnitude of the
cell-mediated immune response.
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Principal component analysis (PCA) of data from these experiments assists
interpretation of the complicated interactions of a number of infection parameters.
When dose is removed as a contributory variable, the responses of inoculated
sheep are clearly defined by the results of the PCA. The two principal components
extracted from the multivariate analysis of six infection variables provides
distinction between sheep infected with different doses of this isolate of FMDV.
The two components of the model are distinct in that none of the variables are
loaded highly for both components. The first component describes the size of the
immune response (humoral and cell-mediated) whilst the second component
describes the effect of delayed immune responses.
The first component of the PCA model distinguishes between sheep inoculated
with 105 TCID50 and those inoculated with 106 TCID50. All parameters of the first
component have been shown to contribute towards a reduction in transmission
during these experiments. The first compartment of the PCA seems to describe the
force by which the host immune response counters initial challenge and then
restricts dissemination and infectiousness by destruction of virus at portals of exit.
The difference in infection with 104 and 105 TCID50 is perhaps too slight for all
individual animals to be distinguished by component 1, although sheep inoculated
with 104 TCID50 are on average loaded higher for this component than sheep
inoculated with 105 TCID50.
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Sheep inoculated with the optimum dose of virus for transmission (104 TCID50)
are distinguishable by PCA from sheep inoculated with higher doses by the second
component. The variables responsible for this component are incubation period,
time interval to peak plasma IFN-y production and level of peak viraemia (minor
contribution). The time allowed for viral replication (prior to interference by
immune mechanisms) has been shown to influence the level ofFMDV infection in
this study and the results of this PCA confirm this finding. It is surprising that
peak viraemia is not loaded more strongly for this component but it has been
shown from this study that when TV-s is shorter viraemia is also shorter. The
strong loading of Ty-s for the first component may explain the absence of a strong
loading for viraemia on the second component. The components of the PCA
described here define groups of sheep in distinct clusters related by the dose they
received. Although dose was excluded from PCA analysis, the influence of the
size of the infectious dose on variables is clearly seen in results of this
multivariate analysis. Such a system, shown to work well for these experiments,
could be used to estimate the dose of virus received by a naturally infected sheep
if enough parameters were measured and available for PCA.
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CHAPTER 5: SERIAL PASSAGE OF FOOT-AND-MOUTH
DISEASE VIRUS IN SHEEP
5.0 Introduction
The outbreak of foot-and-mouth disease (FMD) in Greece during 1994 suggested
that certain strains of foot-and-mouth disease virus (FMDV), under certain
conditions, were maintained poorly in sheep populations. The experiments
described in this chapter attempted to assess transmission and infection of
sequential groups of sheep in a well defined experimental situation. Crucial to the
design of these experiments was to ensure a consistent exposure period for
sequential groups of sheep. Preliminary experiments (results not shown) were
performed using only one animal box within the isolation unit. During these
experiments, new susceptible groups of sheep were introduced after the earliest
definitive sign of FMD. Analysis of these experiments found that due to the early
nature of excretion of FMDV by infected sheep, a considerable proportion of viral
excretion was lost before the introduction of the next sheep group. For these
reasons, it is difficult to expose recipient groups of sheep to the total viral
excretion of the donor group and ensure that the total virus excretion from these
animals is in the presence of their recipient group. To counter these problems the
experiment was designed so that each recipient group was exposed to the same
proportion of the total virus excreted by the donor group. Other preliminary
experiments (results not shown) demonstrated that a 12 hour exposure period was
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insufficient to allow transmission to occur beyond the second group. The exposure
period was therefore set at 24 hours for these experiments. All contact groups of
sheep were to receive virus for 24 hours by moving "up-stream" and following
this period, spend 24 hours donating virus. Staggering of the inoculation of G1 was
performed to make sure that some sheep in G1 had reached peak infectivity when
G2 was brought into contact.
5.1 Experimental design
Two identical experiments were performed within a high security isolation unit
using four groups of eight sheep, termed groups 1-4 (Gl-4). Groups were housed
in individual boxes for three days prior to the start of the experiment. Inoculation
of G1 was staggered to ensure an equal distribution of peak infectiousness. For this
purpose, half of G1 (termed Gib) were moved in to a separate box on day 0 while
the first half were inoculated (termed Gla). All sheep were inoculated with 105
TCID50 of FMDV type O Greece 23/94 in 2 ml of M25 buffer (see appendix)
intranasally using a 2 inch-length of sterile rubber tubing. The movements of
groups between boxes are shown in figure 5.1. Each experiment was continued
until all infected animals were no longer infectious (7 days after the cessation of
viraemia) and sufficient time had been allowed for incubating susceptibles to
become apparent (10 days). All uninfected animals were challenged at the end of
each experiment by intranasal inoculation of 105 TCID50 of FMDV type O Greece
23/94 in 2 ml of M25 buffer. All sheep movements took place at the same time
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each morning. Sheep groups were moved along a "dirty" corridor, starting with
the highest group number. The corridor was disinfected thoroughly after each
movement. Following movement of sheep all animals were sampled. Sampling
started with the lowest group. All staff were disinfected thoroughly before moving
to a different box.
5.1.1 Inoculum preparation
FMDV type O Greece 23/94 (originally isolated from ovine epithelium using
primary calf thyroid cells; BTY) was passed again in BTY cells before titration as
described in section 2.3. This stock virus was aliquoted and stored at -70°C. The
required dilutions for inoculation were calculated and virus stock diluted
immediately prior to administration with the required volumes of M25 phosphate
buffer. All inoculum solutions were re-titrated immediately upon return to the
laboratory to confirm the given dose.
5.1.2 Sampling protocol
On each day of the experiments, 5 ml of peripheral blood and 5 ml of peripheral
blood mixed with EDTA were taken for serology and virus isolation respectively.
Negative controls were taken on day -3 and day 0. Total serum antibody responses
were measured as described in section 2.5. Virus isolation from plasma was
performed as described in section 2.2. In the laboratory, 250 pi of whole blood
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was added directly to 750 pi of TRIzol LS (Gibco, BRL) for RNA extraction and
subsequent quantitative RT-PCR for viral RNA as described in section 2.10. Four
additional 250 pi aliquots of whole blood were stored at -70°C in cryotubes. All
sheep were examined daily for clinical signs of FMD in the mouth and on all four
feet. Rectal temperatures were recorded daily. Oesophageal-pharyngeal fluid (OPF)
was taken from every animal on days estimated as 30 and 33 days post-infection
for the first experiment and 35 and 38 days post-infection for the second
experiment. For G2-4, where the exact point of infection was unknown, the point
of infection was assumed to be 48 hours prior to the onset of viraemia. This is a
conservative estimate of the interval reported by Gibson et al. (1986). For
uninfected and subclinically infected animals, sampling was performed at the same
time as the last member of the same group. OPF samples were processed as
described in section 2.6. OPF samples positive by virus isolation were not tested






































































Experimental animals have been classified throughout this analysis according to the
levels of infection defined in section 2.12. Susceptible animals were challenged at
the end of each experiment to confirm susceptibility to FMDV. A summary of the
infection status of sheep from both experiments is shown in table 5.1.
Experiment 1 Experiment 2
G1 G2 G3 G4 G1 G2 G3 G4
Clinical 7 4 7 5 7 3 6 3
Inapparent 0 2 1 2 1 2 0 1
Subclinical 1 1 0 1 0 1 1 3
Susceptible 0 1 0 0 0 2 1 1
Total infections 8 7 8 8 8 6 7 7
Table 5.1. Numbers of sheep in each infection class following serial passage
experiments. Clinical infections were defined as those where clinical signs of FMD
occurred. Inapparent infections were classified as those where viraemia occurred but
without the occurrence of clinical signs. Subclinical infections were defined as those where
seroconversion was the sole indicator of FMDV infection. Susceptible animals were
challenged at the end of each experiment to confirm susceptibility to FMDV.
5.2.1.1 Experiment 1
The viraemic periods and probang results for all groups are shown in figure 5.2.
Of the eight G1 sheep, 7 developed clinical FMD. The other member (UB54)
developed subclinical FMD, seroconverting 5 days post inoculation. Two in-
contact animals developed subclinical FMD, UB66 from G2 and UB76 from G4.
Only one sheep remained susceptible throughout the course of the experiment,
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UB60 from G2. UB60 was challenged at the end of the experiment and developed
clinical FMD within 4 days of inoculation.
5.2.1.2 Experiment 2
The viraemic periods and probang results for all groups are shown in figure 5.3.
All 8 G1 sheep developed viraemia. One did not develop lesions. A total of 5 sheep
developed subclinical FMD; one each from G2 and G3 (UF95 and UF88
respectively) and 3 from G4 (UF78, UF77 and UF76). Four sheep were still
susceptible at the end of the experiment; UF92 and UF93 from G2, UF85 from G3
and UF80 from G4. All susceptible sheep were challenged at the end of the
experiment and all developed clinical FMD within 4 days of inoculation.
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5.2.2. Indicators of infection
5.2.2.1 Clinical foot-and-mouth disease
To assess the level of clinical FMD, both the mean number of vesicular lesions and
the mean number of sites on which lesions occurred were calculated for groups of
sheep from both experiments. Five possible sites were used in calculating the mean
number of sites affected (all four feet and the mouth). The mean number of
vesicular lesions for clinically infected sheep is shown in table 5.2. The mean
numbers of sites affected are shown in table 5.3. One-way analysis of variance
(ANOVA) using the least significant difference (LSD) method for multiple
comparisons was performed for lesions data (numbers and sites affected) for
viraemic sheep, for both experiments. All data showed no significant departure
from normality (p>0.05) using the Kolmogorov-Smirnov test and were consistent
with homogeneity of variance using the Levene test (p>0.05). There were no
significant differences (p>0.05) between any group means for both experiments,
for both measures of clinical FMD.
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Mean number of vesicular lesions
Group Experiment 1 N Experiment 2 N
1 2.0 (0.1-3.9) 7 2.8 (0.9-4.6) 8
2 1.7 (0.1-3.2) 6 1.8 (0.4-3.2) 5
3 2.4 (0.5-4.3) 8 1.3 (0.5-2.2) 6
4 1.8 (0.4-3.6) 7 1.3 (0.3-2.3) 4
Table 5.2. Mean number of vesicular lesions per viraemic
sheep during serial passage. Numbers in brackets show 95%
confidence limits of the mean. ANOVA with multiple comparisons
using the LSD method showed no significant differences (p>0.05)
between groups for experiment 1 (df=3,24; F=0.09; p=0.966) and
for experiment 2 (df=3,19; F=1.06; p=0.389).
Mean number of sites affected
Group Experiment 1 N Experiment 2 n
1 1.4 (0.9-1.9) 7 2.4 (0.9-3.9) 8
2 1.4 (0.1-2.2) 6 1.6 (0.1-3.4) 5
3 1.5 (0.5-2.5) 8 1.3 (0.5-2.2) 6
4 1.4 (0.4-2.5) 7 1.3 (0.0-3.3) 4
Table 5.3. Mean number of sites affected by FMD per viraemic
sheep during serial passage. Numbers in brackets show 95%
confidence limits of the mean. Only five sites were included for
analysis (four feet and the mouth). ANOVA with multiple
comparisons using the LSD method showed no significant
differences (p>0.05) between groups for experiment 1 (df=3,24;
F=0.14; p=0.937) and for experiment 2 (df=3,19; F=0.85; p=0.482).
5.2.2.2 Antibody responses
The mean peak total serum antibody levels for each group are shown in
table 5.4. The time interval in days between the onset of viraemia and the
start of seroconversion (Tv_s) has been calculated as a possible indicator of
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the duration of the infectious period. Mean values of Tv.s for both groups
are given in table 5.5. ANOVA using the LSD method for multiple
comparisons were performed on log2 transformed data for peak antibody
production and Tv_s for both experiments. There were no significant
differences (p>0.05) between any group means for both measures and both
experiments. Humoral immune response data showed no significant
departures from normality (p>0.05) using the Kolmogorov-Smirnov test
and were consistent with homogeneity of variance using the Levene test
(p>0.05).
Group Mean peak antibody titre1
Experiment 1 N Experiment 2 N
1 5405 (7132-4096) 7 7132 (10809-4705) 8
2 6208 (8192-4390) 6 9410 (17510-5043) 5
3 4390 (6654-3104) 8 8192 (16384-4096) 6
4 4390 (7643-2702) 7 7643 (10086-5792) 4
Table 5.4. Mean peak antibody levels for viraemic sheep
during serial passage. 1Mean values and standard errors of the
mean were calculated by back-transformation of log2 coded
individual peak antibody titres. Values in brackets show 95%
confidence limits of the mean. ANOVA of log2 transformed raw data
(with multiple comparisons using the LSD method) showed no
significant differences (p>0.05) between groups for experiment 1




Group Experiment 1 N Experiment 2 N
1 2.9 (3.7-2.0) 7 2.6 (3.1-2.2) 8
2 2.8 (3.3-2.4) 6 2.6 (3.3-1.9) 5
3 3.0 (3.0-3.0) 8 2.2 (2.6-1.7) 6
4 2.9 (3.5-2.2) 7 2.5 (3.4-1.8) 4
Table 5.5. Time interval in days between the onset of viraemia
and the start of seroconversion (TV-s) for groups from serial
passage experiments. Values in brackets show 95% confidence
limits of the mean. ANOVA of log2 transformed raw data (with
multiple comparisons using the LSD method) showed no significant
differences (p>0.05) between groups for both experiment 1
(df=3,24; F=0.12; p=0.946) and experiment 2 (df=3,19; F=1.07;
p=0.385).
5.2.2.3 Viraemia
5.2.2.3.1 Length of viraemia
The mean length of viraemia for groups from both experiments is shown in table
5.6. Non-parametric analysis of data using the Mann-Whitney U test showed no
significant difference between the distributions of any groups (p>0.05).
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Mean length of viraemia
Group Experiment 1 N Experiment 2 N
1 2.9 (2.2-3.5) 7 3.3 (2.7-3.8) 8
2 2.8 (2.4-3.3) 6 3.0(2.1-3.9) 5
3 3.0 (2.6-3.4) 8 2.3(1.8-2.9) 6
4 3.0 (2.2-3.8) 4 2.3(1.5-3.0) 4
Table 5.6. Mean length of viraemia for sheep during serial
passage experiments. Values in brackets show 95% confidence
limits of the mean. Non-parametric Mann-Whitney U test analysis
showed no significant difference in the distributions between any
groups (p>0.05).
5.2.2.3.2 Quantification of viral loads
Levels of viral RNA in blood were measured by quantitative RT-PCR (as described
in section 2.10). Initially, all blood samples positive by virus isolation were
quantified to determine the point of peak viraemia. Peak samples were then assayed
a further two times and the mean value determined. Individual mean peak titres and
arithmetic group means are shown in table 5.7. For the purpose of this analysis,
UF94 from experiment 2 (G2) has been placed in G4. UF94 was viraemic 5 days
after the other 4 sheep in G2 had developed viraemia. It is unlikely that either
UF94 had a very long incubation period or that the other 4 members of G2 had
excessively long infectious periods. UF94 was therefore most likely infected by
back transmission from G3.
Raw data for peak viral loads were transformed to achieve no significant departures
from normality (p>0.05) using the Kolmogorov-Smirnov test and consistency with
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homogeneity of variance using the Levene test (p>0.05). For this purpose,
experiment 1 data was square-root transformed and experiment 2 data natural log
transformed. ANOVA using the LSD for multiple comparisons of group means
was performed on transformed data for both experiments (tables 5.8 and 5.9).
Results of the ANOYA showed a significant (p<0.05) effect of group on mean
peak viral RNA titre for experiment 1 (F=3.48; df=3,24; p=0.03) but not for
experiment 2 (F= 1.31; df=3,19; p=0.10). Post-hoc multiple comparisons
revealed significant differences (p<0.05) between G2 and G4 for both experiments
and between G1 and G2 for experiment 1.
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Group Mean individual peak titres1 N Arithmetic log 10
mean titre2
Experiment 1
1 4025,8862,2663,3845,2861,1977,15862 7 3.69 (4.05-3.32)
2 3236,17155,20120,14047,6368,25038 6 4.02 (4.55-3.49)
3 15941,9539,9301,17041,6886,8863,181,133 8 3.60 (4.38-2.82)
4 3605,3417,5415,3394,1054,4107,885 7 3.40 (3.69-3.11)
Experiment 2
1 717,6109,6162,374,3709,4412,10216,6230 8 3.50 (3.93-3.08)
2 30169,13238,6048,602, 5/43 3.81 (4.52-3.07)
3 37397,6355,6066,388,1081,4718, 6 3.58 (4.30-2.85)
4 378, 674, 1537, 1313, 4933 4/53 2.88 (3.37-2.48)
Table 5.7. Peak viral RNA loads from blood measured by quantitative RT-PCR for
sheep from serial passage experiments. 1Peak viral loads were determined by
assaying every blood sample positive by virus isolation. Peak samples were assayed
three times and the mean calculated. Values are in TCID50/ml estimated from a
standard curve of known titre from assay in tissue culture. Arithmetic mean for groups
has been calculated as the mean from log10 transformed individual peak titres. infection
of UF94 occurred as a result of back-transmission from G3 and so for the purpose of
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Figure 5.4. Mean peak viral loads determined by quantitative RT-PCR for
experiment 1. Error bars show 95% confidence limits of the mean. Blue, red, green and
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Figure 5.5. Mean peak viral loads determined by quantitative RT-PCR for experiment 2.
Error bars show 95% confidence limits of the mean. Blue, red, green and purple bars show
G1-4 respectively. For the purpose of analysis UF94 has been placed in G4 as detailed in
section 5 2.2.3.
127
Expt 1 Analysis of variance
Group 1 2 3 4
1 0.032 0.544 0.372
2 0.092 0.004
3 - 0.133
Table 5.8. Results of ANOVA with multiple
comparisons using LSD of square-root
transformed peak viral load data from experiment
1. Numbers indicate p values. Bold values indicate
significant differences (p<0.05).
Expt 2 Analysis of variance
Group 1 2 3 4
1 0.416 0.813 0.065
2 0.563 0.026
3 - 0.054
Table 5.9. Results of ANOVA with multiple
comparisons using LSD of natural log
transformed peak viral load data from experiment
2. Numbers indicate p values. Bold values indicate
significant differences (p<0.05).
5.2.3. Carrier status
The results of probang samples taken are shown in table 5.10. Each sheep was
sampled on two separate days. To assess whether the occurrence of a positive
sample (by virus isolation) on the second day was independent of the occurrence of
a positive sample on the first day, the effect of repeated sampling on the
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occurrence of positive results by virus isolation was tested using the McNemar
change test (Sokal & Rohlf, 1995). This test assesses whether previous testing (in
this case the first probang samples) significantly associates with the results of
subsequent tests (in this case the second probang samples) for related samples.
Analysis of data by this method indicates there is no significant association
(p>0.05) between the results of repeated sampling (G= 1.425, n=26; G values
approximate the %2 distribution with one degree of freedom). Therefore, the results
of samples from each of the two dates from an animal are independent of each
other. The results of this analysis suggest that either the presence of virus in OPF
is intermittent during the recovery phase or that the sampling technique lacks the
necessary repeatability. An animal from which virus could be isolated from OPF
on the first date of probang sampling but was then negative on the second date of
probang sampling was included as a carrier in further analysis. The weakness of
probang sampling does not allow us to make clear inferences about clearance of
persistent FMDV infection. Therefore, a positive carrier has been defined as an
animal from which virus has been isolated from at least one probang sample.
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Number of carrier animals
Group Experiment 1 Experiment 2
30dpi
1
33dpi Total 35dpi 38dpi Total
1 6 6 6 3 6 6
2 4 1 4 0 1 1
3 6 3 6 3 1 3
4 2 2 3 0 1 1
Table 5.10. Number of carrier animals in groups from serial
passage experiments. A carrier animal has been defined as any
sheep where virus was isolated from OPF.1days post infection; the
point of infection for in-contact groups was estimated as described
in section 5.1.2.
5.2.3.1 Markers of carrier status
5.2.3.1.1 Infection status
The results of probang sampling stratified by final infection class are shown in
table 5.11. The one sheep that developed carrier status following subclinical FMD
was from Gl. The persistence of FMDV in this animal may be linked to the route
of inoculation and not as a result of the natural infection process.
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Infection class N No. positive Proportion positive
carriers
Clinical 42 24 0.57 (0.72-0.42)
Inapparent 9 5 0.56 (0.88-0.24)
Subclinical 8 1 0.13(0.36-0.00)
Susceptible 5 0 0.00
Table 5.11. Proportions of carrier animals by infection class
for serial passage experiments. Data for both experiments has
been combined. A carrier animal has been defined as any sheep
where virus was isolated from OPF. Numbers in brackets show
95% confidence limits of the mean.
5.2.3.1.2 Peak viral load
For the purpose of presentation, peak viral loads have been categorised according
to magnitude. The proportion of sheep developing carrier status and the
corresponding peak viral loads are shown in table 5.12. To assess the association
between viral load and the development of carrier status, logistic regression was
performed on uncategorised continuous peak viral load data against categorical
carrier status (1= carrier, 2=non-carrier). This analysis shows that the level of
peak viral load has a highly significant association with the development of carrier
status (df=l; Wald statistic=5.980; p=0.009).
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Peak viral load N Positive Proportion
(TCiDso/mi) carriers positive
4.0-4.9 16 13 0.81 (1.00-0.62)
3.0-3.9 25 12 0.48(0.68-0.28)
2.0-2.9 10 3 0.30(0.02-0.58)
Table 5.12. Proportions of carrier animals and corresponding
viral loads following serial passage experiments. Data for both
experiments has been combined. A carrier animal has been
defined as any sheep where virus was isolated from OPF.
Numbers in brackets show 95% confidence limits of the mean.
Logistic regression analysis shows peak viral load to have a highly
significant relationship with the development of carrier status
(p<0.01).
5.2.3.1.3 Clinical FMD
Table 5.13 shows the number of vesicular lesions and sites affected by clinical
FMD with the corresponding number of carrier animals for both experiments
combined. For the purpose of this analysis, data from sheep with greater than two
lesions or sites affected has been combined. Only viraemic animals were included
in the analysis. To assess the association between both measures of the severity of
clinical disease and the development of carrier status, logistic regression was
performed on clinical signs data against categorical carrier status (l=carrier,
2 = non-carrier). This analysis shows that the numbers of lesions (df= 1; Wald
statistic=0.003; p=0.955) and the number of sites affected (df= 1; Wald




of lesions N Carriers Proportion N Carriers Proportion
or sites positive positive
0 13 6 0.46 (0.73-0.19) 9 5 0.56 (0.88-0.24)
1 14 8 0.57 (0.83-0.24) 17 11 0.65 (0.88-0.42)
2 14 9 0.64 (0.89-0.39) 15 9 0.60 (0.96-0.24)
>3 10 6 0.60 (0.90-0.30) 7 4 0.40 (0.70-0.10)
Table 5.13. Proportions of carrier animals with number of vesicular lesions and
sites affected by clinical FMD following serial passage experiments. Data for both
experiments has been combined. A carrier animal has been defined as any sheep
where virus was isolated from OPF. Numbers in brackets show 95% confidence limits of
the mean.
5.2.3.1.4 Serum antibody response
Table 5.14 shows the peak serum antibody responses of sheep and the
corresponding number of carrier animals for both experiments combined. To
assess the association between the peak serum antibody titre reached and the
development of carrier status, logistic regression was performed on log2
transformed peak antibody titre data against categorical carrier status (1= carrier,
2=non-carrier). This analysis shows that the peak antibody titre reached had no
significant association with the development of carrier status (df=l, Wald statistic
= 1.25, p=0.268).
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Peak antibody N Carriers Proportion
titre positive
1:2048 1 1 1.00
1:2896 6 4 0.67
1:4096 7 3 0.43
1:5792 14 10 0.71
1:8192 17 8 0.47
1:11586 4 3 0.75
1:16384 1 0 0.00
1:23186 1 0 0.00
Table 5.14. Peak antibody titres and corresponding numbers
of carrier animals for viraemic sheep from serial passage
experiments. Data for both experiments has been combined. A
carrier animal has been defined as any sheep where virus was
isolated from OPF.
5.3. Force of infection
To estimate the force of infection {A) for individual groups the rate of transfer of
animals from susceptible to viraemic status with time was examined (Anderson &
May, 1991). For calculation of A the rate of decline of susceptible animals at time
t, S(t), from 8 at t=0 to S(t) was modelled as
— = -pis (1)
dt
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where J3 is the transmission rate and / is the number of infectious animals. A is
defined as the rate at which susceptible animals develop viraemia and is given by




Solving equation (3) gives
= Sne* (4).
Taking natural logarithms of each side of equation (4) gives a linear regression line
with form
Figure 5.6 shows the number of animals developing viraemia with the sum of viral
loads for animals viraemic on each day of the experiment. Each individual graph
shows the sum of viral loads for sheep within that group and for those in-contact.
For G2 and G3 this includes sheep groups both upstream and downstream.
Estimates of A were obtained for G2-3, from both experiments, using equation (5)
from linear regression analysis of natural log transformed numbers of sheep that
have not developed viraemia with time (table 5.15). A is an estimate of the rate of
InSt = InS0 - At (5).
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new infections (clinical and inapparent) and is based on the overall infectiousness
within the box, not of individual sheep. Variation in the force of infection, A,
would be attributed to differences in the number of infectious animals but estimates
of A do not account for variation in the infectiousness of individual sheep. The
period over which A was estimated was the time between the first point of exposure
(contact with viraemic sheep) and the last point of exposure (or the time the last
sheep developed viraemia if all did so within the exposure period) and are given in
table 5.15.
The relationship between A and exposure to viraemic animals is shown in figure
5.7. Four measures of exposure were used in testing this relationship, all calculated
over the chosen time period: (1) the average daily sum of all viraemias to which
susceptibles were exposed (irrespective of group), (2) the average daily sum of
viraemias from other groups to which susceptibles were exposed, (3) the average
daily sum of viraemias within the group to which susceptibles were exposed, and
(4) the average number of viraemias irrespective of group (qualitative) to which
susceptibles were exposed. The first three measures of exposure rely on the
assumption that the level of viraemia is directly proportional to the infectiousness
of the animal at that time. All measures of exposure are positively correlated with
A. There is a significant positive correlation between A and the average number of
sheep viraemic on each day of the exposure period. Figure 5.8 shows A for each
contact group during serial passage and the corresponding mean peak viral load for
both experiments.
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Experiment 1 G2 Experiment 2 G2
Experiment 1 G4 Experiment 2 G4
Day post inoculation of G1
Figure 5.6. Transmission and exposure for individual contact groups from
serial passage experiments 1 and 2. Individual graphs show the number of
sheep who have not developed viraemia (green line) and the sum of viraemias
each group was exposed to. The sum of viraemias is shown in terms of the group
in question (broken line) and that of in-contact groups (red line) Viral loads were
determined by quantitative RT-PCR as described in section 2.10. Viral loads
either side of the peak were only assayed once.
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Expt. Group Period used (days)1 A R'
1 2 1-14 0.084 (0.111-0.058) 0.747
3 6-14 0.120 (0.215-0.026) 0.470
4 9-18 0.085 (0.140-0.080) 0.448
2 2 1-19 0.052 (0.061-0.041) 0.876
3 6-18 0.071 (0.100-0.041) 0.624
4 11-16 0.022 (0.075-(-)0.030) 0.283
Table 5.15. Estimated force of infection (A) for contact infected sheep
groups from serial passage experiments. A was estimated for each
group by linear regression analysis. Numbers in brackets show 95%
confidence limits. 1The time period used for calculating A was the time
between the first point of exposure (contact with first viraemic sheep) and
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Figure 5.7. Relationship between force of infection (X) and measures of
exposure for contact infected sheep groups from serial passage experiments.
Graph A shows the average sum of viraemias for all sheep present. Graph B shows
the average sum of viraemias of sheep from other groups. Graph C shows the
average sum of viraemias of sheep from within the group. Graph D shows the
average number of viraemic animals present from any group. Each data point
represents a contact group (3 groups from each experiment). Spearman's rank







Figure 5.8. Estimated force of infection (T) and mean peak viral load for sheep groups
from serial passage experiments. The red line shows results from experiment 1. The blue line
shows results from experiment 2. Error bars show 95% confidence limits of the mean.
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5.4 Discussion
The experiments described here have attempted to simulate group-to-group
transmission of FMDV. Through passage of virus through four groups of sheep, an
attempt has been made to detect a reduction in the infectivity of FMDV and the
level of infection with passage through sheep groups. The isolate used in this study
was taken from the height of the 1994 epizootic of FMDV on mainland Greece.
These experiments have attempted to quantify transmission and infection
parameters that may have contributed to the epidemiological characteristics of the
epizootic. Genetic selection of a less transmissible mutant of this virus is unlikely
to have occurred during serial passage either in the field or during these
experiments. Such a virus would have a lower fitness and by definition viral
evolution does not favour such a process, although bottlenecks during transmission
in small populations may result in stochastic loss of fitness. The more probable
hypothesis is that an infected sheep flock is unable to amplify, or in fact maintain,
the levels of virus received from donor animals per sheep. This would lead to a
gradual reduction in the force of infection {A) with flock-to-flock transmission.
Estimation of A from these experiments shows there was a marked decline in the
value for G4 when compared to that estimated for the preceding group (G3).
Conversely, the estimate of A for G2 is less than that estimated for G3 but this is
likely due to the route of infection for Gl. The characteristics of infection for G1
should perhaps not be related to those of the other groups in the experimental
analysis. These animals were directly inoculated and the route of infection is
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known to influence the degree of infection and transmission from these animals.
For both of the experiments described here, G1 had lower levels of viraemia than
the first contact infected group (G2) and the estimated value of A is less than for the
contact-to-contact transmission steps (G2 to G3 & G3 to G4). This evidence
suggests that the transmission step from G1 to G2 is an experimental anomaly and
cannot be directly related to later events. Despite the low A estimated for G2, the
mean peak viral load for this group was for both experiments higher than for G3.
This may be an experimental "artefact" and not a naturally occurring event. The
high viraemias seen for G2 sheep that became infected early may be due to
effective contact with G1 sheep excreting large amounts of virus, as is known to
occur for directly inoculated sheep (Donaldson et al., 1970). For such an excretion
profile, where the vast majority of virus is excreted in a 24 hour period, effective
contacts must be made during this peak. When such an event occurs the contact
animal would receive a very large dose of virus. Of the 11 G2 sheep that developed
clinical FMD it is likely that only 3 were infected through contact with G1 (those
that became viraemic less than 72 hours after exposure to viraemic G1 sheep). All
of these sheep had levels of peak viraemia above the mean for their group. The
only published data for FMDV excretion from contact infected sheep shows that
the excretion profile is more protracted than for directly inoculated sheep (Sellers
et al., 1977). Such excretion profiles increase the probability of infection but
reduce the infectious dose. The first two passages in these experiments seem to
follow this pattern.
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Initially there are less transmission events (G1 to G2) but with higher viraemias.
This is followed by a period of higher transmission rate but with a lower level of
infection. There is a higher rate of movement of sheep from susceptible to viraemic
(A) but a lower level of infection (assessed by the level of viraemia) for later
transmission steps. There is then a reduction in the force of infection with
transmission from G3 to G4 and the level of infection is reduced further still, such
that the mean peak viraemia for G4 is significantly less than for G2. The first
passage through contact-infected sheep (G2) corresponds with an increase in the
force of infection but subsequent transmission fails to enhance the transmissibility
and replicative ability of this virus in sheep.
Estimation of A for the three contact groups of sheep from both experiments shows
a statistically significant association between A and the average number of viraemic
sheep present on each day of the exposure period. No significant association can be
found between A and any measure of quantified viral loads although all measures
are positively correlated with A. The small number of data points (N=6) has
restricted the statistical power of testing this relationship. Despite limitations due to
the data size, the result of correlation testing suggests that the infectiousness of a
sheep infected with this isolate of FMDV may not be directly related to the level of
viraemia at that time. The relationship between the level of viral load and the level
of excretion is unknown although studies have shown that excretion of FMDV by
sheep following infection can occur up to 48 hours prior to the onset of clinical
signs (Donaldson et al., 1970; Sellers & Parker, 1969), a time point that coincides
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well with the onset of viraemia. Results from the serial passage experiments
described here show that the onset of vesicular disease (if present) occurs at a mean
of 1.2 days after the start of viraemia (range -1 to 4 days). Studies on the excretion
of FMDV from infected sheep have not determined the time of onset of viraemia so
assumed excretion profiles can only be placed according to clinical signs. For these
experiments the number of viraemic sheep that fail to develop vesicular lesions
means such a method is inappropriate for this analysis. Published data of the
excretion of FMDV from infected sheep has been collated for use in a computer
model to predict the airborne spread of FMDV (Sorenson et al., 2000). The
excretion profile used in the model assumes that 97.2% of the total virus excreted
by FMDV infected sheep occurs over a three-day period, a period found from
these experiments to be the modal length of the viraemic period. The shape of the
excretion profile has been shown to be strain-specific (Donaldson et al., 1970) with
considerable variation in the amounts of virus excreted, in terms of both peak
values and total amount. It is therefore speculative to make any specific
assumptions on the levels of this isolate excreted by infected sheep during the
course of these experiments.
The route of infection for FMDV does suggest it is unlikely that viraemia is
essential for infectiousness. Epithelial cells of the oro-nasopharynx are known to be
the primary sites of replication for FMDV following inhalation of aerosol (Burrows
et al., 1981) and replication in the mucosa of the upper respiratory tract (Terpstra,
1972). Virus has been detected in OPF and nasal fluids prior to the onset of
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viraemia for both intranasally and contact infected sheep (McVicar & Sutmoller,
1972; Sharma, 1978; Sharma & Murty, 1981). These facts suggest that viral
excretion is, in the early stages of infection, independent of viraemia, although
excretion that occurs at the height of viraemia may be augmented by high levels of
circulating virus reaching portals of exit. This evidence suggests it is unlikely that
the levels of virus in blood will reflect the relative amounts of virus excreted at that
time. Perhaps this is best reflected in the relationship between A and measures of
viral load. The best correlation is between A and viraemic days. Quantitative
measures of viraemia show less association with the force of infection than
qualitative measures.
Figure 5.8 shows clearly how the level of infection (assessed by the level of peak
viral load following infection) has decreased with passage group. Reasons for the
increase in viral load for G2 compared to G1 have been explained earlier. For
these reasons G2 can in a number of respects be classed as the first group in the
serial passage. The level of infection at the end of the chain (G4) is significantly
different to that at the start (G2) for both experiments. There has been a significant
reduction in the level of FMDV infection after passage through only 2 groups of
sheep. The transmission characteristics for FMDV from the two experiments
described here agree with observations on the natural behaviour of this isolate in
the field. These experiments show a reduction in both the force of infection and the
level of infection after passage of virus through 2 contact groups of fully
susceptible sheep.
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A statistically significant association between the level of viraemia and the number
of carrier animals has been found from these experiments. The lower viraemias
seen with later passage groups would explain the lack of carrier animals found
during the field epidemic. At the height of the epidemic when large numbers of
clinical cases of FMD were reported, potential carrier animals were destroyed.
Later in the epidemic, when clinical FMD was not reported, A and the level of
infection may have been much reduced and the probability of developing carrier
status would have declined. It has been suggested that the development of carrier
status may occur independently of viraemia (McVicar et al., 1970). The results of
these experiments suggest that for sheep infected with this isolate of FMDV this is
not the case and that the probability of an infected animal developing persistent
FMD increases with the level of viral load, and experimentally with low group
number. Development of carrier status in sheep would seem to be a secondary
event that follows acute infection and not a separate development following
infection of primary sites of replication. The observation that vaccinated cattle can
develop into carriers following contact with live virus, and in the absence of
viraemia, does suggest that the process may be more complex.
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CHAPTER 6: GENERAL DISCUSSION
This research has been performed in an attempt to understand the dynamics and
biology of the transmission of an isolate of foot-and-mouth disease virus (FMDV)
in sheep populations. FMDV is regarded as one of the most infectious animal
viruses but the outbreak of foot-and-mouth disease (FMD) in Greece during 1994
suggested that under certain circumstances transmission might not be so efficient.
Analysis of field data from the epidemic has been combined with dose-dependent
and serial passage experiments to assess their effects on the transmission of
FMDV. It is clear from this work that the behaviour of this isolate of FMDV in
sheep populations is different to that classically assumed for FMDV. It would be of
great interest to determine whether other isolates of FMDV behaved in this manner
in sheep, particularly those isolates that showed high morbidity for sheep in the
field. The role of sheep in the recent outbreak of FMD in the UK shows how
important it is to understand the behaviour of FMDV in sheep.
In the field, this isolate of FMDV exhibited behaviour such that the outbreak was
termed "self-limiting". The Greek island of Lesbos served as an ideal environment
for transmission of FMDV and enabled the initial amplification of the force of
infection to occur. Without this initial kick-start it seems unlikely that the spread of
FMD on the mainland would have been as severe. It has recently been suggested
that sheep should be vaccinated in areas of high density but not in areas of low
density (Donaldson, 2000). The observations from the outbreak in Greece during
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1994 suggest that areas of high sheep density may provide the ideal environment
for transmission and maintenance of FMDV whilst areas of low sheep flock density
may not. The isolate of FMDV responsible for the 1994 epidemic in Greece was
not sheep adapted. Perhaps the self-limiting nature of the outbreak in Greece is due
to a combination of the predilection of the strain and the large proportion of
FMDV susceptible livestock being sheep.
Upon reaching the mainland the force of infection began to fall. Results of serial
passage experiments performed here show this process beginning to occur in a well
defined transmission biased system. Estimated measures of the force of infection
for sequential stages of the experiments show a fall with natural transmission steps.
The level of infection for individual animals (assessed by peak viral load) has also
been reduced significantly. It is difficult to assess whether the estimated force of
infection would have continued to decline with passage beyond the three groups of
naturally infected sheep used in the experiment. The field evidence, coupled with
the experimental data, does suggest that sheep would have been unable to amplify
the levels of virus to a level necessary to increase the force of infection and so
further reductions would seem likely. If the level of viraemia in the field were to
fall as seen during serial passage experiments, eventually it would reach levels such
that infection would be described as subclinical. At some point, viraemia would fall
below the level detectable in the laboratory and below that capable of causing
generalised lesion formation. Sheep with a low level of infection may not be
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infectious. There is only anecdotal evidence to suggest that subclinically infected
sheep are capable of transmission.
It is improbable that the reduction in the level of infection seen here is due to
genetic alteration. The evolutionary force required to induce attenuation or
adaptation of FMDV to a particular host species is likely to take place over a long
period of time. It seems unlikely that genetic alteration would contribute to a "self-
limiting" virus, as this would require selection of a less transmissible virus over a
relatively short time period. The pig adapted virus in Taiwan (1997) adapted to a
niche environment to enhance the reproduction ratio of the virus. This was not the
case for the outbreak in Greece during 1994. Viruses isolated from the course of
the serial passage experiments described here will be subjected to genetic analysis
at a later date to confirm this inference.
The dose-dependent experiments described here demonstrate the complex
relationship between virus and host. Early immune responses seem to control the
infectiousness of the host and subsequent viraemia. The very high doses of FMDV
used here, although capable of infecting inoculated animals and causing clinical
FMD, resulted in no transmission to in-contact susceptible animals. The optimum
dose of FMDV was just above the minimum infectious dose. Immunologically,
sheep respond well to this isolate. High doses seem to stimulate innate immune
mechanisms to such an extent that replication and the resultant infectiousness are
compromised. Dose-dependent experiment also show that the level of infection of
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in-contact animals is less than that of the donors. From dose-dependent
experiments the mean level of viraemia of in-contact infected sheep was in both
cases less than that of the donor animals. For the analogous transmission step from
serial passage experiments (G1 to G2) the level of viral load was higher for the in-
contact infected sheep. In these experiments the ratio of inoculated animals to in-
contact animals was higher (1:1) compared to the dose-dependent experiments
(1:2). This would have led to a greater contact rate between infecteds and
susceptibles and the contributory effects of multiple contacts may have led to the
increased level of infection for in-contact sheep. This is further evidence to suggest
that sheep held at high density are a greater risk of disseminating FMD.
The results of these experiments suggest that sheep may not act well as amplifiers
of certain strains of FMDV. If the predilection of the strain is established it may be
feasible to, as long as they are kept separate from pigs and cattle, to allow FMDV
infection in sheep to run its course in epidemic environments. The fact that lambs
are highly susceptible to FMDV must be considered at the time of lambing.
However, in an epidemic environment where the presence of seropositive animals
in the national flock is not acceptable, sheep will have to be slaughtered. As has
been demonstrated with the recent outbreak of FMD in the UK, the nature of the
disease in sheep is such that they may serve as asymptomatic disseminators of
FMDV. It should be taken into account that this work has only been carried out
with one isolate of FMDV. Other strains, particularly sheep adapted strains, may
behave differently.
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The behavior of FMDV in sheep populations is very different to its behavior in
cattle and pig populations. In groups of cattle and pigs there is considerable early
spread of infection throughout the susceptible population and the nature of clinical
disease makes detection more likely. Rapid spread through the population results in
a large number of animals becoming infected early and subsequently a large
amount of concentrated virus is excreted. Creation of plumes of virus in this way is
of great importance for viral dissemination and enhances the risk of airborne
spread over long distances. Sheep, on the other hand, do not transmit infection well
within a flock and at best seem capable of viral "turn over" rather than
amplification as is seen with cattle and pigs.
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CaCl2 (anhydrous) 0.1 g
MgCl2.6H20 0.1 g











Phenol Red (0.1%) 1.5 litres
Stock aminoacids 5.0 litres
Vitamin concentrate 400 ml
Penicillin 100 IU/ml final conc.
Streptomycin 100 IU/ml final conc.
Neomycin 100 IU/ml final conc.
Polymixin 100 IU/ml final conc.
Distilled H20 To 100 litres
Eagle's-HEPES, pH 7.2-7.4
Eagle's medium 1 litre
HEPES 5.0 g





Distilled H20 To 1 litre
Antigen detection ELISA blocking buffer, pH 7.2-7.4
PBS 500 ml
Tween 20 0.25 ml
Skimmed milk 25 g
Phosphate buffered saline-Tween (PBST)
PBS 500 ml
Tween 20 0.25 ml
Phenol Red Solution (5%) 10 ml
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